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ABSTRACT 
I  
Abstract 
The T4 lysozyme, from bacteriophage T4, has the ability to lyse bacterial cell walls; thus it has 
attracted immense attention as an antimicrobial agent. Nonetheless, the production of T4L cannot meet 
our needs. All of the work presented here in this thesis, focuses on the potential exploitation of synthetic 
gene-coding T4L protein to improve the economic feasibility of antimicrobial agent production by 
producing a natural antimicrobial agent. Synthetic t4l was constructed to enhance the production of 
recombinant T4L for industrialization purposes after its successful expression in the two hosts. Therefore, 
comparing the wild type and synthetic t4l from nucleotide sequences until protein 3D structure was 
unavoidable. Two T4L genes that have been studied are the wild type and the synthetic one. The later, 
new synthetic (t4l) gene was produced by using codon-based modification with alternation of triplet 
nucleotides that encodes two specific amino acid residues at position 6 and 12 in a polypeptide chain of 
T4L protein. Wild type and synthetic t4l have variants in the size of nucleotides, 459 bp and 491 bp, 
respectively, but both have equal amino acids size, 164 a.a. The comparison of 3D protein structure 
showed us how both protein structures have structural similarity by calculating RSMD; 0.17 for backbone 
coordinate and 0.14 for carbon alpha coordinate. Also, structure sequence identity was 98.87% by using 
the alignment of editor Jalview. Additionally, developed T4L gene with codon-based modification has 
been cloned into three vectors with different promoters in order to be expressed in selected strain of E. 
coli then T. reesei. Expression of a synthetic t4l by using E. coli system was by transforming of the three 
plasmids-bearing-synthetic t4l separately, into two strains of E. coli, JM109 and BL21(DE3)pLysS. The 
later had been tested for its sensitivity and/or resistance to the lysis action of lysozyme enzyme before the 
transformation-taking place by using agar halo assay. Resistance of BL21(DE3)pLysS strain to lysozyme 
activity has been confirmed with our halo assays, which keep this strain to be a good choice for expression 
of this lysis enzyme. Also, the results of both enzyme digestion and PCR showed that the synthetic t4l had 
successfully transformed into selected E. coli strain. Furthermore, the expression of that gene had been 
showed on SDS-PAGE assay with an apparent molecular mass of approximately 18 kDa. However, 
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determine and measure the recombinant T4L production is still needs more research to work on it. 
Additionally, T. reesei has the capacity to produce extracellular enzymes in very large amounts. Invention 
relates method for efficiently expressing and producing recombinant protein of T4L from T. reesei QM6a 
by using protoplast-based transformation method. T4 lysozyme synthesis operon (t4l) cloned in three 
different plasmids was successfully integrated in T. reesei QM6a genome, to form recombinant strains, 
termed as ST4L1, ST4L2, and ST4L3. T4 lysozyme encoded by the t4l was successfully expressed in two 
of our recombinant strains, which are ST4L2 and ST4L3, as confirmed by SDS-PAGE. We successfully 
constructed a recombinant T. reesei strain expressing exogenous gene, specifically t4l that originated from 
phage T4 and integrated into the genome. Recombinant T4L was stably produced by those strains with a 
selected antibiotic supplementation. We develop a novel system by which foreign gene can be 
successfully inserted into the chromosome of T. reesei, where transcription can be driven by cbhI 
promoter, with the need for addition of inducer that is carbon source. T4 lysozyme production by this 
system was stable and the system may be useful in biotechnological fermentation processes. Success of 
such a technology will facilitate production of T4L for industrialization and medical purposes.   
 
 
 
 
 
 
 
 
 
  
LAY SUMMARY 
III  
Lay Summary 
Alexander Fleming discovered the antibacterial action of lysozyme in 1922. Since then, scientists have 
been increasingly studying lysozyme and determining further applications related to medical and/or 
industrial fields, which ended up with positive evaluations from World Health Organization and Food 
Drug Administration.  In the current study, I worked on one of the most active lysozymes in sterilization, 
which is T4 lysozyme (T4L). Likewise, as an essential factor in the advancement of genetically 
engineered DNA techniques has been the development of genetic transformation systems. One of the 
significant challenges of this study is the development of a genetic transformation system for a species in 
which none exists. Collecting and applying methods that have been successfully applied to other species 
and determining how best to apply these methods to fungal organism in this study: Trichoderma reesei, 
was the major challenge. Successfully, modified gene encoding T4L, which studied bioinformatically and 
expressed in E. coli system, was introduced into Trichoderma reesei’s genome; moreover, expression of 
that gene developed a novel strain. However, T4L is an enzyme that is essential for protection against 
bacterial infection. The success of such technology developments will facilitate the production of T4L for 
industrialization purposes.  
 
 
 
 
 
 
 
 
  
ACKNOWLEDGMENTS 
IV  
Acknowledgements 
I would like to express my sincere appreciation and deepest gratitude to my supervisors Dr. Wensheng 
Qin for his enthusiasm in research, effective guidance, and continuous encouragement and support 
throughout this thesis. His guidance and patience was most helpful particularly when this project research 
experienced any difficulties. Completely, I would like to show my great appreciation for his help in my 
study, research, and life during the time period of this thesis work in Canada. 
Furthermore, I am full of gratitude to the supervisory committee members; Dr. Kam Leung and Dr. Zi-
Hua Justin Jiang, and external examiner Dr. Tim Xing for donating their valuable time and effort by 
lending their knowledge and support to my thesis. I want to extend heartfelt thanks to many other 
professors and the graduate students for their invaluable comments and their great patience in my graduate 
studies at Lakehead University.  
I want to thank many colleagues, Dr. Miranda Maki and Dr. YuanYuan, just to name a few, for their 
help in some experiments, consultation and comments on the work, and preparation of the thesis. Special 
thank to Dr. Xi Chen for the donation of the synthetic t4l gene, without which this work could not have 
been possible. I would also like to thank Dr. Wely Floriano, the instructor of Advanced Bioinformatics 
course, for her support and generous effort along with valued inputs, advices and helpful suggestions 
throughout the course and the applied bioinformatics study. 
Finally, financial support provided by Jazan University through Saudi Arabian Cultural Bureau in 
Canada, as well as research funding are highly appreciated. 
 
 
 
 
 
 
  
TABLE OF CONTENTS 
V  
Table of Contents 
Table of Contents .................................................................................................................................... V!
List of Tables ....................................................................................................................................... VII!
List of Figures ..................................................................................................................................... VIII!
Chapter I: Introduction .......................................................................................................................... 1!
Abstract ................................................................................................................................................................. 1!
1.1. History ............................................................................................................................................................ 1!
1.2. Biomolecular Structure and Function ............................................................................................................ 3!
1.2.1 Biological and Molecular Functions of Lysozyme!....................................................................................................!3!
1.2.2 The Structure of Lysozyme!................................................................................................................................................!4!
1.2.3 Lysozyme in Different Species!.........................................................................................................................................!6!
1.2.3.1 T4 Lysozyme!.......................................................................................................................................................................................!7!
1.2.3.2 Hen Egg White Lysozyme!...............................................................................................................................................................!8!
1.2.3.3 Human Lysozyme!...............................................................................................................................................................................!8!1.2.3.4!Lysozyme!in!Other!Vertebrates!...............................................................................................................................................!10!
1.2.4 Bioengineering and Protein Modifications!................................................................................................................!10!
1.3. Lysozyme Applications ................................................................................................................................ 13!
1.3.1 Medical Applications of Lysozyme!..............................................................................................................................!13!
1.3.2 Industrial Applications of Lysozyme!...........................................................................................................................!14!1.3.2.1!Antimicrobial!Food!Packing!......................................................................................................................................................!15!1.3.2.2!Gram!Positive/Negative!Bacteria!Versus!Sensitivity/Resistance!to!Lysozyme!.................................................!17!1.3.2.3!Mechanism!of!Resistance!to!Lysozyme!Activity!..............................................................................................................!18!1.3.2.4!Inhibitory!Activity!of!Lysozyme!Against!Microorganisms!Other!than!Bacteria!................................................!21!
1.4. Lysozyme Detection ..................................................................................................................................... 21!
1.4.1 Factors Influencing Lysis Efficiency!...........................................................................................................................!22!
1.4.2 Agar Plate Bioassays!.........................................................................................................................................................!22!
1.4.3 Activity in Media Measurements (Turbidimetric)!...................................................................................................!23!
1.4.4 Thermostability of Lysozyme on SDS-PAGE!..........................................................................................................!25!
1.4.5. Immunoassays!....................................................................................................................................................................!26!
1.4.6. Biosensor!..............................................................................................................................................................................!28!
1.4.7 Flow injection Chemiluminescence System!..............................................................................................................!29!
Thesis objectives ................................................................................................................................................. 30!
Figure and Table legend ...................................................................................................................................... 32!
References ........................................................................................................................................................... 34!
Chapter II: Computational Analysis of T4 Lysozyme ....................................................................... 39!
Abstract ............................................................................................................................................................... 39!
2.1. Introduction .................................................................................................................................................. 40!
2.1.1. Approach ................................................................................................................................................... 43!
2.2. Methodology ................................................................................................................................................ 43!
2.2.1 VNC Software!.....................................................................................................................................................................!43!
2.2.2. Exhaustive comparison between two versions of T4 lysozyme!........................................................................!44!2.2.2.1.!Retrieving!nucleotide!and!amino!acid!sequence!............................................................................................................!44!2.2.2.2.!Database!similarity!and!multiple!sequence!alignment!................................................................................................!45!
2.2.2.3. Motifs profile!...................................................................................................................................................................................!46!2.2.2.4.!Analyzing!protein!3D!structure!..............................................................................................................................................!47!
2.2.3. Comparison of T4 lysozyme 3D protein structures!...............................................................................................!48!
2.3. Results and Discussion ................................................................................................................................. 48!
2.3.1. Retrieving nucleotide sequence and protein translation!.......................................................................................!48!
2.3.2. Protein database similarities and multiple sequence alignment!.........................................................................!49!
2.3.2.1 EMBOSS package analysis!..........................................................................................................................................................!49!
2.3.3. Motifs analysis!...................................................................................................................................................................!50!
2.3.4. Analyzing T4 lysozyme 3D protein structure!..........................................................................................................!51!
  
TABLE OF CONTENTS 
VI  
2.3.5. Comparison of T4 lysozyme 3D protein structures!...............................................................................................!52!
Conclusion ........................................................................................................................................................... 52!
Figure and Table legend ...................................................................................................................................... 54!
References ........................................................................................................................................................... 62!
Chapter III: Expression of a Synthetic T4 Lysozyme Gene in Escherichia coli ............................. 63!
Abstract ............................................................................................................................................................... 63!
3.1. Introduction .................................................................................................................................................. 63!
3.2. Materials and Methods ................................................................................................................................. 65!
3.2.1. Synthetic T4 Lysozyme Gene!.......................................................................................................................................!65!
3.2.2. Bacterial Strains and Media!...........................................................................................................................................!66!
3.2.3. Halo Assay for Analysis of Host Strains!...................................................................................................................!66!
3.2.4. Electrotransformation of E. coli JM109 and BL21(DE3)pLysS!.......................................................................!67!
3.2.5. PCR Amplification of Synthetic t4l!............................................................................................................................!68!
3.2.6. Expression of T4 Lysozyme from Transformants and SDS-PAGE!.................................................................!69!
3.3. Results and Discussions ............................................................................................................................... 70!
3.3.1. Halo Assay!...........................................................................................................................................................................!70!
3.3.2. Synthetic t4l amplification!.............................................................................................................................................!71!
3.3.3. Detection of Recombinant T4 Lysozyme!..................................................................................................................!71!
Conclusions ......................................................................................................................................................... 72!
Figure legend ....................................................................................................................................................... 73!
References ........................................................................................................................................................... 75!
Chapter IV: Expression of T4 Lysozyme gene in Trichoderma reesei ............................................. 77!
Abstract ............................................................................................................................................................... 77!
4.1. Introduction .................................................................................................................................................. 77!
4.2. Materials and Methods ................................................................................................................................. 80!
4.2.1. Strains, Media, and Cultivation Conditions!..............................................................................................................!80!
4.2.2. Antifungal Plate Assay!....................................................................................................................................................!80!
4.2.3. Protoplasts Preparation and Genetic Transformation!............................................................................................!81!
4.2.4. Confirmation of Positive Clones!..................................................................................................................................!82!4.2.4.1.!Genomic!DNA!Isolation!and!st4l!Amplification!...............................................................................................................!82!4.2.4.2.!Transformants!Identification!and!Sequencing!................................................................................................................!83!
4.2.5. Detection of Recombinant T4 Lysozyme!..................................................................................................................!83!
4.3. Results and Discussions ............................................................................................................................... 84!
4.3.1. Strain optimization and Halo Assay!............................................................................................................................!84!
4.3.2. Production of Protoplast and Genetic Transformation!.........................................................................................!85!
4.3.3. Confirmation of Positive Clones!..................................................................................................................................!86!4.3.3.1.!Characterization!of!T4!Lysozyme!Transformants!..........................................................................................................!86!4.3.3.2.!Positive!clone!Identification!and!Relevancy!.....................................................................................................................!87!
4.3.4. Detection of Recombinant T4 Lysozyme Production!...........................................................................................!87!
Conclusions ......................................................................................................................................................... 88!
Figure and table legend ....................................................................................................................................... 90!
References ........................................................................................................................................................... 94!
Chapter V: General Discussion and Future Directions ..................................................................... 96!
References ......................................................................................................................................................... 103!
 
!
!
!
!
!
!
!
  
LIST OF TABLES 
VII  
List of Tables 
Chapter I: Introduction  
Table 1 ...................................................................................................................................................................................... 33!
Table 2 ...................................................................................................................................................................................... 33!
Table 3 ...................................................................................................................................................................................... 33 
Chapter II: Computational Analysis of T4 Lysozyme  
Table 1 ...................................................................................................................................................................................... 58!
Table 2 ...................................................................................................................................................................................... 58!
Table 3 ...................................................................................................................................................................................... 59!
Table 4 ...................................................................................................................................................................................... 59!
Table 5 ...................................................................................................................................................................................... 60!
Table 6 ...................................................................................................................................................................................... 60!
Table 7 ...................................................................................................................................................................................... 61!
Table 8 ...................................................................................................................................................................................... 61 
Chapter IV: Expressing and Producing T4 Lysozyme through Recombinant Trichoderma reesei  
Table 1 ...................................................................................................................................................................................... 93 
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
  
LIST OF FIGURES 
VIII  
List of Figures 
Chapter I: Introduction  
Figure 1 ..................................................................................................................................................................................... 32!
Figure 2 ..................................................................................................................................................................................... 32!
Figure 3 ..................................................................................................................................................................................... 32 
Chapter II: Computational Analysis of T4 Lysozyme  
Figure 1 ..................................................................................................................................................................................... 54!
Figure 2 ..................................................................................................................................................................................... 54!
Figure 3 ..................................................................................................................................................................................... 55!
Figure 4 ..................................................................................................................................................................................... 55!
Figure 5 ..................................................................................................................................................................................... 56!
Figure 6 ..................................................................................................................................................................................... 57!
Figure 7 ..................................................................................................................................................................................... 57 
Chapter III: Expression of a Synthetic T4 Lysozyme Gene in Escherichia coli   
Figure 1 ..................................................................................................................................................................................... 73!
Figure 2 ..................................................................................................................................................................................... 73!
Figure 3 ..................................................................................................................................................................................... 73!
Figure 4 ..................................................................................................................................................................................... 74!
Figure 5 ..................................................................................................................................................................................... 74!
Figure 6 ..................................................................................................................................................................................... 67 
Chapter IV: Expressing and Producing T4 Lysozyme through Recombinant Trichoderma reesei  
Figure 1 ..................................................................................................................................................................................... 90!
Figure 2 ..................................................................................................................................................................................... 90!
Figure 3 ..................................................................................................................................................................................... 90!
Figure 4 ..................................................................................................................................................................................... 91!
Figure 5 ..................................................................................................................................................................................... 91!
Figure 6 ..................................................................................................................................................................................... 92!
!
 
 
 
 
 
 
 
 
 
 
 
  
LIST OF ABBREVIATIONS 
IX  
List of Abbreviations  
°C Celsius degree 
bp Base pair 
ddH2O Double-distilled water 
DNA Deoxyribonucleic acid 
dNTPs  deoxyribonucloside triphosphates 
E. coli  Escherichia coli 
EDTA  Ethyl diphosphate tetra acetic acid 
et al.  et alia (and other; Latin) 
g  gram or relative centrifugal force (RCF) 
h  hour 
Kb kilo bases 
kDa kilo Dalton 
L, l litre(s) 
LB Luria-Bertani  
M molar(s) 
M. luteus   Micrococcus luteus 
mg  milligram(s) 
min  minute(s) 
ml  millilitre(s) 
mM millimolar(s) 
MW molecular weight 
OD  optical density 
PCR polymerase chain reaction 
PEG polyethylene glycol 
PG peptidoglycan  
pH negative logarithm of hydrogen ion concentration 
SDS-PAGE  Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
Sec second(s) 
T. reesei  Trichoderma reesei 
t4l T4 lysozyme gene 
Ul micro litre(s) 
UV Ultraviolet 
V voltage(s) 
 
  
CHAPTER I                                                                                                                    INTRODUCTION 
1  
Chapter I: Introduction  
Abstract 
Lysozyme has attracted immense attention as an antimicrobial agent because of its ability to lyse the 
bacterial cell wall. Further, it is found in a wide variety of body fluids and in cells of the innate immune 
system. Lysozyme can act as muramidase or as a Cationic Antimicrobial Peptide (CAMP). This literature 
review covers a fundamental introduction to lysozyme in terms of biological and molecular structure and 
functions. Based on enzyme nomenclature, the lysozyme is classified as glycosylases under hydrolases. 
Therefore, the structure of this enzyme is discussed here to better understand its domains, the interface 
between domains, ligand binding domains, and active sites. Additionally, several studies have attempted 
to generate a modified lysozyme gene, either for large-scale production or that which is more suitable for 
industrialization purposes. Nonetheless, the production of recombinant lysozyme has not yet met our 
needs. Bioengineering and protein modifications that have been applied in other studies have been 
outlined. Additionally, lysozymes in different species have been summarized. Also, mechanisms of 
lysozyme-resistance with few bacteria have been discussed. As lysozyme has many applications in 
medical and industrial principles, it is important to review and study some of these applications. Some 
studies have used different methods for lysozyme detection; therefore, some of those methods are 
considered in this review. Ultimately, this type of review gives a basic understanding for researchers; 
likewise, it is considered a valuable starting point.  
Key words: Lysozyme Biomolecular Structure and Functions, Medical and Industrial Applications, 
Detection
1.1. History 
Lysozyme (1, 4-N-acetylmuramidase, E.C.3.2.1.17) is a small cationic protein first reported by 
Laschtschenko in 1909 (Burgess, 1973). Lysozyme’s discovery, however, is attributed to Alexander 
Fleming. Fleming’s report stated that lysozyme was a “powerful bacteriolytic element found in human 
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tissues and secretions” (Fleming, 1922). Fleming was at the time suffering from a cold and he is reported 
to have allowed drops of his nasal secretions to fall onto an agar culture plate, which was thickly 
colonized with bacteria. The plates were incubated at a certain temperature for a number of hours; bacteria 
grew extensively. There was complete radial inhibition beyond the nasal mucus on the plate. This 
experiment was later termed the lysoplate. Fleming concluded that the nasal secretions contained an 
enzyme capable of bacterial lysis; it was later named lysozyme. 
With the success of his preliminary experiment, Fleming continued to work with lysozyme, testing its 
antibacterial properties with several different bacteria. Fleming reported the discovery of a small round 
bacterium particularly vulnerable to the effects of lysozyme. This bacterium was named Micrococcus 
lysodeikticus (now referred to as Micrococcus luteus) due to its ability to display lysis (Fleming, 1922). 
Fleming diluted the nasal secretions in saline and added them to a thick suspension of the M. luteus. 
Within minutes of incubation at 37˚C the opaque bacterial solution had cleared. This experiment was later 
termed the Turbidimetric test (Fleming & Allison, 1927). Fleming (1922) is quoted as saying his 
experiments “clearly demonstrated the very powerful inhibitory and lytic action which nasal mucus has 
upon Micrococcus lysodeikticus.”  Fleming also showed increased levels of lysozyme in patients with 
pyogenic infections (pus producing) such as meningitis, the first indication that lysozyme could be a 
marker for sepsis.  
Since Fleming’s initial discovery in 1922 of lysozyme in tears and nasal secretions, a great deal of 
literature has accumulated on its structure, function, genetics, biosynthesis, regulation, enzyme activity 
and properties. Lysozyme is one of the most important factors of innate immunity, possessing 
antibacterial, antiviral, antitumor and immune modulatory activities. There has been interest in lysozyme 
as a “natural” antibiotic. Lysozyme is a unique enzybiotic in that it exerts not only antibacterial activity, 
but also antiviral, anti-inflammatory, anticancer and immunomodulatory activities (Helal et. al., 2010). 
The ordinary lysozyme, which has already been industrialized, originates from chicken egg whites, while 
T4 lysozyme (T4L) originates from phage T4. Until now, there has been no T4L industrialization globally 
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(“BRI of CAAS,” 2011, p. 4). Success of an advanced technology will facilitate production of T4L for 
industrialization and medical purposes. 
1.2. Biomolecular Structure and Function 
1.2.1 Biological and Molecular Functions of Lysozyme  
Lysozyme is an outstanding bacteriolytic enzyme that has the ability to hydrolyse glycosidic bonds of 
1,4-beta-linkages between N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM) in 
peptidoglycan (PG), which is form the cell walls of prokaryotes (e.g., bacteria) (Mir, 1977; Akinalp et. al., 
2007) (Figure 1). In addition, its lysis activity has also been reported to inhibit viruses and eukaryotes, 
including fungi and parasites, in the absence of typical PG in their cell walls. However, the lysis of yeast 
and mold has been explained by the presence of an important component of their cell walls called chitin. 
Indeed, chitin has the same β-(1-4) glycosidic bonds as that of the bacteria PG, except that the chitin bond 
links two NAG residues rather than NAG and NAM. In other words, the lysozyme also possesses chitinase 
activity. Furthermore, the inhibition of Entamoeba histolytica by lysozyme can be explained by the 
presence in its membrane of lipopeptidophosphoglycan (LPPG), which can react with the enzyme in a 
similar manner as the PG (Benkerroum et. al., 2008). 
Lysozyme represents an important class of polysaccharide-hydrolyzing enzymes. Lysozyme hydrolyses 
chitin, a linear polymer found in insects, crustaceans, and fungi cell walls, while chitinase (EC 3.2.1.14) 
enzyme catalyzes the breakdown of chitin also. Furthermore, chitinase is a key enzyme in the plant 
defense system against fungal infection. Nonetheless, the chemical similarity between the two-
polysaccharide substrates leads to the fact that some lysozymes can hydrolyse chitin; however, they do so 
less efficiently than their natural substrate and vice versa. Thus, some lysozymes could be considered 
good chitinases and, reciprocally, some chitinases can cleave PG, the natural substrate of lysozymes. 
Nevertheless, there is no obvious amino acid sequence similarity found between these two types of 
enzymes (Wohlkonig et. al., 2010).  
The antimicrobial activity of lysozyme has been extensively demonstrated in vitro or in physiological 
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fluids and secretions, including milk, blood serum, saliva, and urine. The antimicrobial activity of milk 
lysozyme, as part of the unspecific innate defense mechanism, is also well established. Specifically, it acts 
independently by lysing sensitive bacteria or acts as a component of complex immunological reactions to 
enhance the phagocytosis of bacteria by macrophages. Therefore, it contributes to the innate protection 
from milk spoilage after drawing (i.e., bacteriostasis period) (Benkerroum et. al., 2008). Lysozyme also 
has a Cationic Anti-Microbial Peptide (CAMP) function that leads to bacterial death via the 
destabilization of the cytoplasmic membrane (Le Jeune et. al., 2010). 
Lysozyme is recognized to be non-dialyzable, soluble in water and a weak saline, insoluble in alcohol 
and ether, resistant to heat and desiccation, and stable at room temperature (Burgess, 1973), stable at 
acidic pH and labile at alkaline pH (Jolles, 1969). The understanding of the biochemistry and genetics of 
lysozyme enzymes, their phylogenetic relationships, and methods of estimation will make them more 
useful in a variety of processes in the future (Patil et. al., 2000). Overall, lysozyme is one type of enzyme 
capable of hydrolyzing cell membrane polymers such as in fungal, some algae, and most bacteria; 
generally playing important roles in protecting plants and animals against infections and pathogens 
(Wohlkonig et. al., 2010). 
1.2.2 The Structure of Lysozyme 
Lysozyme was one of the first enzymes for which the X-ray structure was determined. Furthermore, 
several classes of lysozymes have been identified based on their sequence similarities. The best known 
ones includes C-type (chicken-type), G-type (goose-type), and V-type (viral type) (Wohlkonig et. al., 
2010). Since the discovery of lysozyme, many investigators have studied this enzyme. For example, Wolff 
(1927) reported on its chemistry; Hoder (1931) on its relation to immunology; Anderson (1932) on its 
importance in vitamin A deficiency; Corper (1932) on its relation to tuberculosis; Meyer et. al. (1936) on 
its purification and properties; and Meyer (1936) and his group on the mechanism of its action (Daly, 
1938). 
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Despite the variability in the amino acid composition and sequence of lysozyme molecules, amino 
acids of the catalytic center of active sites are well conserved to maintain the hydrolytic function of the 
enzyme from different sources. In particular, glutamic acid (Glu35) and aspartic acid (Asp52) residues are 
directly involved in the breakdown of the glycosidic bond between NAG and NAM. Their presence in the 
catalytic center is, thus, crucial for the hydrolytic activity of the enzyme. Glutamic acid acts as a proton 
donor through the free carbonyl group of its side chain, while aspartic acid acts as a nucleophile that 
generates a glycosyl-enzyme intermediate, which then reacts with a water molecule to give the product of 
hydrolysis and release the enzyme uncharched. However, the amino acid sequence of known lysozyme 
has revealed that aspartic acid is not consistently present in the active sites of lysozyme molecules. In 
contrast, substitution of glutamic acid has resulted in a complete inactivation of the enzyme, which 
confirms the critical role of this amino acid in the enzymatic activity of lysozyme, regardless of its origin 
or the class to which it belongs (Benkerroum, 2008). 
Furthermore, for lysozyme action mechanisms, there is one polysaccharide ligand and two structural 
domains. Structural domains are primarily alpha helical and beta sheet. These two domains form a cleft 
and the ligand binds in the cleft between the two domains with polysaccharide (Alberts et. al., 2010). In 
other words, the polysaccharide serves as a joint between the two active sites of lysozyme, Glu35 and 
Asp52. Following this process, lysozyme hydrolyses glycosidic bonds in that polysaccharide. 
Since Fleming’s report, the potential of lysozyme has attracted considerable interest over many years 
(Gorin et. al., 1971). As an example, hen egg white lysozyme (HEWL) is very similar to human 
lysozyme, with 129 amino acids, while human lysozyme has ~148 amino acids and is three to four times 
more reactive than HEW lysozyme as tested with the turbidimetric test (Jolles, 1969; Lollike et. al., 1995). 
However, due to its structural similarity, availability and inexpensiveness, HEWL has been used as a 
model for human lysozyme experiments, making it one of the most well studied enzymes (Lollike et. al., 
1995). 
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There are at least two types of glycosidase: those such as HEWL that have transglycosidase 
activity, and those that do not, such as T4 phage lysozyme (T4L). The mechanistic difference between 
these two types of enzymes is not well understood. Indeed, the transglycosylation reaction can be more 
effective than hydrolysis. In contrast, T4L has no detectable transglycosidase activity. Early structural 
studies showed that three different classes of lysozymes, typified by HEWL, T4L, and goose egg white 
lysozyme (GEWL), have overall similarities in three-dimensional structure, although their amino acid 
sequences are almost entirely different. The active sites of these enzymes have a glutamic acid that is 
highly conserved (Glu-35 in HEWL, Glu-11 in T4L, Glu-73 in GEWL). Otherwise, the active site 
residues show substantial variability. For example, the position of Asp-20 in T4L does not correspond to 
the “essential” Asp-52 of HEWL, and GEWL has no apparent counterpart at all to either of these acidic 
residues (Kuroki et. al., 1999).  
1.2.3 Lysozyme in Different Species 
While lysozyme is widely distributed in prokaryotes and eukaryotes, it has distinct types based on its 
amino acid sequence, protein structure, and catalytic characters, although its catalytic function is still 
consistent (Akinalp et. al., 2007; Dong et. al., 2008). The wide variability in origin and structural, 
antigenic, chemical, and enzymatic properties of lysozyme molecules, requires them to be classified in 
different classes, or types. The conventional, or chicken-type (i.e., c-lysozyme), in which the lysozyme is 
derived from the egg white of a domestic chicken (Gallus gallus), is considered the most studied and best 
known. Although c-lysozyme is typically found in the egg white of birds, it is also purified from various 
tissues and secretions of mammals. Other types of lysozyme that are well-known include the g-type, 
derived from the egg white of the domestic goose (Anser anser); h-type lysozyme from plants; i-type from 
invertebrates; b-type from bacteria (Bacillus); and v-type from viruses (Benkerroum, 2008). 
Fleming stressed that, while lysozyme is most active against nonpathogenic bacteria, it can attack 
pathogenic organisms in some parts of the body when allowed to act in full strength. In addition, he 
showed that lysozyme from different sources affect different organisms: Pneumococcus was attacked only 
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by the lysozyme of pus and Streptococcus haemolyticus only by the lysozyme of tears; Staphylococcus 
and Streptococcus viridans were affected more by the lysozyme of nasal mucus than by that of tears or 
pus. Nevertheless, other researchers worked with egg white lysozyme (which may act differently from 
lysozyme derived from body tissues) and they found that none of a number of Staphylococcus albus 
strains and Staphylococcus aureus tested, showed marked susceptibility to the lytic action of the lysozyme 
(Daly, 1938).  
1.2.3.1 T4 Lysozyme 
Phage T4 is a bacterial virus that infects only bacteria; specifically, it invades and controls bacterial 
metabolism, then terminates its incubation by lyse of infected-bacterial cell wall by T4L (Sulakvelidze et. 
al., 2001; Trun & Trempy, 2004). T4L is similar to the HEWL in the structure of its active sites and sites 
of attack on the PG cell wall. Surprisingly, T4L apparently lyses T4-infected cells by attacking the cell 
wall from the cytoplasmic side (Akinalp et. al., 2007). In other words, it could have active sites on both 
sides of the bacterial cell wall. T4L is a small, well-characterized protein with a molecular weight of 
approximately 18 kDa and dimensions of 5.4 x 2.8 x 2.4 nm (Bower et. al., 1998); it has been the subject 
of extensive structural and genetic studies (Poteete et. al., 1997). T4L is a single polypeptide chain with a 
single NH2-terminal methionine residue and a single COOH-terminal leucine residue. The amino acid 
composition of the protein has been determined (Tsugita et. al., 1968). 
In the 3D protein structure of T4L, the backbone of T4L has two-domain structures, the N-domain and 
C-domain (Baase et. al., 2010), which are linked by a single long α-helical chain. The relative placement 
of the N- and C-terminal domains forms a deep pocket where the ligand can bind. Ligand binding and 
release is associated with motions that are involved in opening and closing of this binding pocket relative 
to those domains as evidenced from experiments and computational studies (Ramanathan et. al., 2011). 
The native structure of this protein has been determined to 1.7Å resolution by X-ray crystallography 
(Poteete et. al., 1997). Systematic probing of the T4L structure has also shown that 74 of the 164 positions 
in its sequence are sensitive to single amino acid substitutions. That is, at least one single amino acid 
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substitution at one of these positions results in at least a 50-fold reduction in function. Not sparingly, the 
most critical amino acid residues in the protein have been found to be buried or solvent-exposed in the 
active site cleft (Poteete et. al., 1997). 
Although lysozymes from T4 phage and hen egg whites have similar catalytic activity, they have non-
homologous amino acid sequences. A comparison of the 3D structure of the phage enzyme with that of 
hen egg whites has been determined in other studies. The 3D structures of HEW and T4L have also been 
seen to be quite different (Matthews & Remington, 1974); it is not clear whether their respective 
mechanisms of catalysis are related. 
However, T4L, produced by the virus phage T4, consists of 164 amino acid residues with a molecular 
weight of 18,700 Da. This enzyme is devoid of disulfide bridges and the only occurring Cys residue is 
located at positions 48 and 97. Further, T4L consists of two domains, C- and N-terminal domains; the 
active site is located in the region between these domains (Malmsten, 2003). 
1.2.3.2 Hen Egg White Lysozyme 
Lysozyme enzyme isolated from hen egg white was the first enzyme submitted for X-ray 
crystallographic analysis and for which a detailed mechanism of action was proposed. It is used 
extensively as a model in protein chemistry, enzymology, protein crystallography, molecular biology and 
genetics, immunology, and evolution. The progress made by the study of these different aspects has been 
reviewed in other studies (Van Dael, 1998). However, the HEWL remains, by far, the richest source of 
this enzyme, with a concentration that ranges between 3400 and 5840 mg/l (Benkerroum, 2008). HEWL is 
a 14,600 Da large monomeric protein that consists of 129 amino acid residues. It has been classified as a 
“hard” protein because the adsorption of HEWL to solid surfaces does not involve any major 
conformational changes (Malmsten, 2003). 
1.2.3.3 Human Lysozyme 
Lysozyme has also been identified from humans in numerous exocrine secretions such as colostrum, 
genito-urinary, gastroduodenal, middle ear, upper and lower airway secretions, saliva, and tears 
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(Hinnrasky et. al., 1990). This enzyme is also found in a wide variety of body fluids, such as respiratory 
secretions, and in cells of the innate system, including neutrophils, monocytes, macrophages, and 
epithelial cells (Le Jeune et. al., 2010). 
Human lysozyme is a key component of the innate immune system and recombinant forms of the 
enzyme represent promising leads in the search for therapeutic agents that are able to treat drug-resistant 
infections. In addition to its catalytic hydrolysis of cell wall PG, human lysozyme also exhibits catalysis-
independent antimicrobial properties. The dual functionality results in a protein that attacks Gram-positive 
and Gram-negative bacterial pathogens; it has been shown to be the most effective cationic anti-
pseudomonal agent in human airways fluids (Gill et. al., 2011). Also, lysozyme has been found in high 
concentrations in human airway secretions collected from patients with chronic pulmonary diseases 
(Hinnrasky et. al., 1990). In addition, one of the major proteins secreted by an established human colon 
adenocarcinoma was identified as lysozyme. Human colon adenocarcinoma cells synthesize and secrete 
several specific proteins, including remarkably large amounts of lysozyme. The lack of diagnostic or 
prognostic markers, as well as the refractory nature of human colon carcinoma to standard chemoimmuno- 
and radio-therapy, makes this an extremely relevant system when investigating the chemistry and biology 
of such secreted macromolecules (Fett et. al., 1985).  
Human lysozyme is a ~148 amino acid single polypeptide chain with a low molecular weight of around 
14.6 kDa (Cabellero et. al., 1999). Human lysozyme is present in the lysosomes of phagocytic cells, 
granulocytes and monocytes (Burgess et. al., 1994). It is released as part of the non-specific immune 
response, and exists among cells of the blood, especially leukocytes. Lysozyme is found in all stages of 
the maturation of the myelocytic series, but not in the myeloblast, eosinophil or basophil (Davis, 1971). 
Monocytes contain large amounts of lysozyme, yet none is found in the lymphocytes. Moreover, in tissues 
lysozyme is mainly found in bone marrow, lungs, intestines, spleen, and kidneys. Lysozyme exists here 
due to the breakdown of neutrophilic granulocytes in these organs (Hansen et. al., 1972). Tissue 
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macrophages release lysozyme into serum, nasal and lacrimal secretions along with various other bodily 
secretions.  
1.2.3.4 Lysozyme in Other Vertebrates 
In higher vertebrates, lysozymes are involved in a broad battery of defense mechanisms and embrace 
several actions such as opsonization, immune response potentiation, and restricted anti-viral and 
antineoplastic activities. Moreover, several studies have indicated that lysozyme may play a role in fish as 
a defense mechanism against infectious disease (Lie et. al., 1989). In addition to their defense role, 
lysozymes also play a role in digestive tasks, for example a dominant gene for high lysozyme activity has 
been detected in cattle (Lie et. al., 1989). Also, high levels of intestinal lysozyme occur in some species of 
house mice in which the enzyme may have assumed a digestive role. This trait appears in only one of two 
closely related lysozyme genes in the same species, resulting in a specific overexpression of lysozyme P 
in the small intestine and leaves a normal expression of lysozyme M in other tissues (Cross et. al., 1988). 
Furthermore, the milk of virtually all mammals contains lysozyme, either as a free soluble protein or 
within leucocytes and lysosomes. Although all lysozyme from milk has been reported as belonging to the 
c-type, it varies widely in terms of structure and physicochemical properties; this includes the folding and 
unfolding status, ability to bind calcium ions, stability to heat or pH and isoelectric point (Table 1). Based 
on lysozyme content in milk, human, equine, and canine, milks are the main representatives of high levels 
of lysozyme (averages 200 to 1330 mg/L group), while bovine, ovine, and caprine milks (Table 2) 
represent low levels of lysozyme (3000 to 6000 times less than the milks of the first group) (Benkerroum, 
2008). Additionally, the concentration of soluble lysozyme in milk varies considerably from one species 
to another, as well as within the same species, depending on various factors such as the breed, stage of 
lactation, parturition, nutrition, udder health, and season of the year.  
1.2.4 Bioengineering and Protein Modifications  
The gene encoding lysozyme is cloned from mammalian tissues and secretions, insects, plants, 
protozoa, bacteria, and viruses and then expressed in some bacteria, fungi, yeast, and plants (Akinalp et. 
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al., 2007). For example, T4L is one of the most thoroughly characterized enzymes through site-specific 
mutagenesis; more than 2,000 single-amino acid substitutions have been done (Malmsten, 2003). Studies 
using T4L variants, which differed from each other by only one amino acid residue or more, provided data 
that clearly related a change in enzyme structure (Bower et. al., 1998). Numerous variants of T4L have 
also been produced through site-directed mutagenesis, including a set of variants that differ by substitution 
of the isoleucine residue at position 3 (Ile 3). Since the Ile 3 residue contributes to a major hydrophobic 
core of T4L, any substitution, at this point, can significantly alter the enzyme’s stability (Bower et. al., 
1998). 
In another work, wild-type T4L enzyme and two site-directed mutants have been used. The site of 
mutation was position 3, which, in the wild-type enzyme, is occupied by an isoleucine (IIe3). Notably, one 
of the mutants increased thermal stability compared to the wild-type enzyme. This mutant had the IIe 
residue in position 3 that was replaced by Cysteine (Cys), which led to the formation of a disulfide bond 
with another Cys residue at position 97. Thermal unfolding of the Cys mutant revealed that the formation 
of the disulfide bond stabilized the mutant by 1.2 kcal/mol relative to the wild-type. However, in the other 
mutant, Ile in position 3 was replaced by the larger amino acid Tryptophan (Trp). This decreased the 
thermal stability of this mutant by 2.8 kcal/mol relative to the wild-type enzyme. This mutant is one of the 
least stable T4L mutants characterized (Malmsten, 2003). Therefore, this residue contributes to the major 
hydrophobic core of the C-terminal domain and helps link the N- and C-terminal domains.  
In other studies, researchers examined the structure of a mutant T4L with a single amino acid 
substitution of 2.5 nm from the active site. The change (replacement of glutamate-128 by a lysine residue) 
caused very little change in the structure of the lysozyme molecule; however, the enzyme had only 4% of 
the catalytic activity as the native enzyme. These results suggest that glutamate-128 participates directly in 
substrate binding or catalysis. The glutamate residue is located on the C-terminal domain, an area that has 
no counterpart in the HEWL molecule. Therefore, it has been suggested that the role of this C-terminal 
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domain is to bind the peptide crosslink that connects neighbouring saccharide strands in the E. coli cell 
wall (Jones, 1984; Grutter & Matthews, 1982).  
Generally, a major goal of protein engineering is to design proteins that demonstrate enhanced stability 
and activity. Among the physical forces that maintain the tertiary structure of proteins, disulfide bonds 
make a substantial contribution. However, the addition of new disulfides has not always increased 
stability. One aspect of this problem is the limited knowledge of the mechanism for which crosslinks such 
as disulfide bonds, stabilize, or destabilize proteins (Mastsumura et. al., 1989). 
From a historical perspective, one of the main reasons for undertaking structural studies of lysozyme 
was to take advantage of genetic screening for temperature-sensitive (TS) mutants. When the lysozyme 
project began, methods for the generation of substitutions by site-directed mutagenesis were yet to be 
developed. Also, the sequence changes in TS lysozymes were determined by classical protein chemistry 
rather than at the DNA level. For example, five TS T4Ls characterized by following approach included 
Arg96 → His (R96H), Met102 → Thr (M102T), Ala146 → Thr (A146T), Gly156 → Asp (G156D), and 
Thr157 → Ile (T157I). On average, these variants reduced the melting temperature of the protein by 10°C 
(Baase et. al., 2010). In a similar study, a multiple mutant was engineered from T4L: 
I3L/S38D/A41V/A82P/N116D/V131A/N144D (PDB Code 189L) and was shown to increase Tm by 8.3°C 
(Zhang et. al., 1995). 
Currently, different methods have been tested to either select or design mutants that retain activity and 
have increased thermostability. These include the use of entropic effects, hydrophobic stabilization, 
helical propensity, salt-bridge interactions, metal binding, S-S bridges, methionine replacement, 
computational procedures, and genetic selection. In cases where disulfide bridges could be engineered into 
T4L, these methods have been very effective in increasing the stability of the protein. A good example is 
the Cys21-Cys142 bridge across the active site cleft of T4L. In this case, “hinge-bending” allowed the 
protein to adjust to accommodate the S-S bridge and the melting temperature increased by 11°C at pH 2 
(Baase et. al., 2010). Futhermore, the genetics of T4 phage lysozyme have been studied extensively and a 
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variety of mutant enzymes have been isolated and characterized. A previous study suggested that the 
residues, Asp 20, Glu 22, Glu 105, Trp 138, Asn 140, and Glu 141, are all essential for full catalytic 
activity on the grounds that changes in any of these amino acids drastically reduce the catalytic 
effectiveness of the enzyme (Matthews & Remington, 1974).  
In contrast, the close proximity of the substituted residue Ile 3 to the active site Glu 11 may also 
contribute to the observed differences in activity among T4L variants because both residues are located on 
the same α-helix. The α-helix content of a protein in a solution is known to increase or decrease in 
response to changes in its environment (e.g., pH, ionic strength, and hydrophobicity of the solvent). A 
T4L variant that is forced to accommodate a relatively large, bulky tryptophan residue in position 3 may 
also make conformational adjustments in adjacent residues. If these effects are propagated along the α-
helix, significant changes in the orientation of the active site may result in an accompanying decrease in 
catalytic activity (Bower et. al., 1998). 
Moreover, the loss of catalytic activity of the T4L variants might also relate to the degree of 
interference caused by mutation in the hinge region of the enzyme. These amino acid substitutions are 
located directly opposite the active site in an area of the molecule that is responsible for the opening and 
closing movement of the active cleft. As such, an enzyme would retain full activity only if the substrate 
were able to force its way past the “hinged” cleft and reach the active site (Bower et. al., 1998). 
1.3. Lysozyme Applications 
1.3.1 Medical Applications of Lysozyme 
Lysozyme has been credited with being an indicator in some hematological malignancy; such as acute 
myeloid leukemia. In addition, an elevated serum lysozyme level could be helpful in differentiating 
between the types of cancer that affect blood, bone marrow, and lymph nodes. However, lysozyme has 
been associated with different abnormalities than those associated with an elevated level of this protein. 
There could be a casual relationship, because activity increases in the gastric juice of patients with peptic 
ulcer and in the colonic sections of patients with ulcerative colitis and regional enteritis (Mir, 1977). 
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Lysozyme lends significant insight, as it is associated with any abnormality in humans who demonstrate 
an elevated level of this important enzyme. 
Hence, deviations in lysozyme levels of blood and urine, for example, have been correlated to 
particular myeloid and renal abnormalities and lysozyme levels have subsequently been used to monitor 
the success of therapy. Although the lysozyme protein can be found in most tissues, studies at the cellular 
level have revealed high levels of lysozyme, specifically in phagocytic cells (including macrophages and 
granulocytes) and the Paneth cells (including the intestine and the proximal tubules of the kidney). While 
the kidney accumulates at least some of its lysozyme from the blood, endogenous lysozyme synthesis has 
been detected in mammalian myeloid cells (Cross et. al., 1988). Additionally, lysozymuria has been 
reported, in various renal tubular disorders, as a manifestation of the disease. Furthermore, discrepancies 
could be caused by differences in methods, patient populations, and stages of disease (Mir, 1977). Future 
studies may reveal various subtypes of lysozyme based on more sophisticated physical and biochemical 
characteristics; these subtypes may reveal more about the cell functions and their sensitivity to antitumor 
drugs. Of note, it was reported that lysozyme is an effective agent for killing HIV in vitro (Song and Hou, 
2003). Thus, lysozyme has potential for future applications in the medical field. 
1.3.2 Industrial Applications of Lysozyme 
Lysozyme enzyme is gaining importance for its biotechnological applications. Specifically, such 
applications are used in agriculture to control plant pathogens, for example. Its high microbicidal activity 
remains, by far, the main virtue explaining its high attention with scientists and industrial stakeholders for 
its practical applications in medical and food industries. Mainly, it is known for its antibacterial activity 
and has been used in food preservation. Although the egg white is the primary source for lysozyme 
production at an industrial scale, other sources, such as mammals’ milk, should not be overlooked, as they 
may contain lysozyme molecules with specific properties that are not present in the conventional egg 
white lysozyme (Benkerroum, 2008). The success in employing lysozyme for different aspects depends on 
the supply of highly active preparations at a reasonable cost (Patil et. al., 2000). 
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Chicken egg white lysozyme characterizes its use in oenology. While it has been used for several years 
in the pharmaceutical and food-processing industries, it has been recently added in some oenology 
processes (e.g. wine maturation). Moreover, lysozyme has recently been introduced to the wine industry to 
control contamination by lactic bacteria; in such industry, lysozyme has been permitted to the level of 100 
mg/L (Benkerroum, 2008, Ferreira et. al., 2011). Furthermore, from a biochemical perspective, lysozyme 
has an optimum activity between 40°C and 45°C and can remain active up to 62°C, which is entirely 
compatible with the temperature used for enzymatic hydrolysis. Also, with regards to the optimum pH 
value, the enzymatic activity of this protein is slightly disturbed within a pH value range between 3.5 and 
7; however, it can remain active between 2 and 10 (Ferreira et. al., 2011). 
Lysozyme also presents the advantage of limiting the use of sulfur dioxide (SO2), a product that is 
often used today to limit microbiological contamination in industrial processes. However, this process is 
expensive and has health-related side effects. Further, lysozyme plays a protective role in difficult 
fermentation. In fact, nitrogen deficiencies make alcoholic fermentation difficult with the risk of 
developing lactic bacteria that degrade fermented food products. However, the addition of lysozyme 
accommodates with this type of problem with high efficiency (Ferreira et. al., 2011). 
Additionally, lysozyme is used as a preservative in many food products that are likely to contain lactic 
bacteria such as cheese, tofu, or sake. The use of lysozyme in brewing processes has won attention and 
there are now many applications for lysozyme in the brewing stages. Lysozyme is effective against most 
lactic bacteria. At the practical level, lysozyme has found applications in food preservation and has 
already been used successfully as an antimicrobial in many foods, particularly cheese. This has received 
positive evaluations from international regulatory agencies such as the World Health Organization (WHO) 
and the Food and Drug Administration (FDA) (Benkerroum, 2008).  
1.3.2.1 Antimicrobial Food Packing 
In order to control microbial growth in foods and improve their shelf life and safety, different 
antimicrobial agents are mixed with the initial food formulations or are applied to food surfaces by 
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dusting, dipping or spraying (Min and Krochta 2005). In recent years there has been greater interest in 
antimicrobial food packaging technologies due to increased food-borne microbial outbreaks caused by 
minimally processed fresh and refrigerated products. Traditionally, antimicrobial additives are mixed into 
initial food formulations to control microbial growth and extend shelf life. However, this strategy is not 
always effective because the protective ability of the antimicrobial agent ceases once it is neutralized in 
reactions and/or interactions in the complex food system and the quality of food degrades at an increased 
rate. In addition, the antimicrobial compound directly added into the food cannot selectively target the 
food surface where spoilage reactions occur more intensively. Antimicrobial packaging is an alternative 
method to overcoming these limitations because the agent slowly releases from the film onto the food 
surface during storage, hence maintaining the critical concentration necessary for inhibiting the microbial 
growth (De Roever 1998, Devlieghere et. al., 2004). 
To prepare antimicrobial films, different synthetic antimicrobial chemicals have been incorporated into 
packaging materials including organic or inorganic acids, metals, alcohols, ammonium compounds or 
amines (Appendini and Hotchkiss 2002; Suppakul et. al., 2003). However, the increasing consumer health 
concern and growing demand for healthy foods have stimulated the use of natural biopreservatives such as 
antimicrobial enzymes and bacteriocins (Suppakul et. al., 2003; Labuza & Breene, 1989). Lysozyme is 
one of the most studied biopreservatives for antimicrobial packaging applications (Han 2000; Quintavalla 
and Vicini 2002). 
Antimicrobial packaging is one of the many applications of active packaging. It is a packaging system 
that is able to kill or inhibit spoilage and pathogenic microorganisms that are contaminating foods (Han 
2000). Also, it is specifically designed to control growth of microorganisms, unlike conventional food 
packaging systems, which are used for shelf-life extension, quality maintenance, and safety assurances 
that could be achieved by various methods. Table 3 shows the application area, when lysozyme is used as 
an antimicrobial agent and packaging materials are used in antimicrobial food packaging. 
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Many researchers have studied lysozyme for biopreservation of foods because of its lytic activity on 
bacteria. Most of the studies related to lysozyme have been focused on HEWL because the enzyme is 
commercially purified from egg white (Chang et. al., 2000). The antimicrobial activity of the enzyme is 
mainly effective against Gram-positive bacteria; however, because the PG layer is surrounded by a 
protective lipopolysaccharide (LPS) membrane, it is ineffective against some Gram-negative bacteria 
(Nakamura et. al., 1991, Ibrahim et. al., 1991). 
With that being said, many researchers have been interested in increasing the antimicrobial spectrum of 
lysozyme. For instance, the combination of lysozyme with EDTA makes lysozyme highly effective on 
Gram-negative bacteria (Mecitoglu et. al., 2006), and conjugates of lysozyme with dextran, 
galactomannan or xyloglucan have good antimicrobial activity against both Gram-positive and Gram-
negative bacteria when applied in combination with mild heating at 50°C (Nakamura et. al., 1992). 
Nonetheless, in several studies lysozyme has been incorporated as a preservative in many packaging 
materials to extend the shelf life of the foods (Appendini and Hotchkiss 1997; Buonocore et. al., 2004; 
Mecitoglu et. al., 2006).  
1.3.2.2 Gram Positive/Negative Bacteria Versus Sensitivity/Resistance to Lysozyme 
While PG in Gram-positive bacterial cell walls is freely accessible to lysozyme, on the contrary Gram-
negative bacterial PG is shielded by the lipopolysaccharidic (LPS) layer of the outer membrane, some 
studies have suggested that resistance of bacteria to lysozyme is not exclusively related to the presence of 
the LPS layer. However, the presence of an outer membrane in Gram-negative bacteria does not provide 
absolute protection against the hydrolytic action of lysozyme. Sensitive Gram-negative bacteria have been 
described, along with mechanisms not hindered by LPS. In addition to the protective effect of LPS against 
the hydrolytic action of lysozyme, Gram-negative bacteria have recently been shown to use another 
strategy that involves specific protein-inhibitors with high affinity to lysozyme (Benkerroum, 2008). 
Specifically, in 1927, Fleming and Allison were first to report resistant strains of Streptococcus. 
Fleming and Allison’s work into the nature of the bacterial resistance continued. Several strains of 
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bacteria were tested with the tears from Fleming’s patients. Fleming found lysozyme was not effective 
against a range of bacteria. These included Haemophilus influenzae, Neisseria meningitidis, Escherichia 
coli, Streptococcus pneumoniae, Klebsiella pneumoniae and group B Streptococci. From these studies, 
lysozyme resistance was characterized as an inability to break down bacteria that are encapsulated with a 
gelatinous polysaccharide layer. This dramatically limits the effectiveness of lysozyme to bacteria that 
have no capsule. Lysozyme is therefore of little value as a therapeutic agent against bacterial growth, but 
the release of lysozyme as a product of phagocytosis and white blood cell turnover may be a useful marker 
for sepsis (Fleming and Allison, 1927).  
1.3.2.3 Mechanism of Resistance to Lysozyme Activity 
The complexity of the composition and structure of peptidoglycan is well known (Le Jeune et. al., 
2010). The pathological effects of peptidoglycan are greatly enhanced by various modifications and 
substitutions to its basic composition and structure (Clarke & Dupont, 1992). While some bacterial species 
are sensitive to lysozyme, the majority of bacteria (like some important human pathogens such as 
Staphylococcus aureus or Neisseria gonorrhoeae, E. faecalis, and Proteus mirabilis) are resistant to 
lysozyme (Le Jeune et. al., 2010; Herbert et. al., 2007). 
In fact, the exact mechanism of lysozyme resistance is not fully understood and may vary according to 
the bacterial strain or species (Benkerroum, 2008). Various mechanisms involved in this resistance have 
been well described in different species of bacteria. Such mechanisms of resistance have been suggested 
such as interference of lysozyme action by surface attachment polymers (e.g., capsular polysaccharides 
and teichoic acids) (Benkerroum, 2008). For example, a high degree of peptide cross-linkage (Bera et. al., 
2005; Herbert et. al., 2007; Benkerroum, 2008), this is a modification of the net negative charge of the 
bacterial cell surface by adding positively charged residues genes, teichoic, and lipoteichoic acids, which 
help bacteria to avoid being killed by antimicrobial peptides or CAMP activity of lysozyme (Herbert et. 
al., 2007; Le Jeune et. al., 2010), and N-acetylmuramic acid residues being modified by a tetrapeptide 
composed of both L and D amino acids. In most cases, these peptide side chains are involved in the direct 
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cross-linking between adjacent glycan strands; however, in some instances, a more complicated 
arrangement exists. For example, a pentaglycine peptide bridges the neighboring peptide side chains 
within the peptidoglycan sacculus of Staphylococcus aureus (Clarke & Dupont, 1992); this is a 
modification of different sites of the PG structure by some type of enzyme (e.g., the peptidoglycan-
specific O-acetyltransferase (OatA) of S. aureus) (Le Jeune et. al., 2010). Similarly, it has been described 
for 11 Gram-positive and Gram-negative species (Bera et. al., 2005), which results in O-acetylation of 
hexosamine residues of the cell wall PG (Benkerroum, 2008) and the N-acetylglucosamine deacetylase 
(PgdA) of Streptococcus pneumonia. These both prevent the binding of lysozyme to its substrate and 
contribute to the muramidase resistance. N-deacetylation of the acetamido group of the hexosamine 
residues (Benkerroum, 2008), incorporation of D-Aspartic acid in the bacterial PG cross bridge, as was 
demonstrated in Lactococcus lactis, and the production of protein-inhibitors specific to lysozyme, N-non-
substituted glucosamine residues in the peptidoglycan, as in Bacillus cereus and Streptococcus pneumonia 
(Bera et. al., 2005).  
Moreover, evading the killing action of lysozyme may also consist of the production of lysozyme 
inhibitors such as the Streptococcal Inhibitor of Complement (SIC) in streptococci, the inhibitor of 
vertebrate lysozyme in E. coli, the periplasmic (or membrane) lysozyme inhibitor of c-type lysozyme (for 
example: Periplasmic Lysozyme Inhibitor of c-type lysozyme in Salmonella enteritidis, or Membrane-
bound Lysozyme Inhibitor of c-type lysozyme in E. coli), which have protective functions (Le Jeune et. 
al., 2010). 
Over recent years, these mechanisms have been gaining attention in research. While there is a general 
agreement that surface attachment polymers and the degree of peptide cross-linking do not account for 
lysozyme-resistance, it is not clear whether there is only a single mechanism of resistance for all bacteria 
or if more specific mechanisms may be used by specific strains or species. However, the above 
mechanisms may be modulated by other factors that are not directly involved in lysozyme resistance. For 
example, the presence of teichoic acid or a high degree of peptide cross-linking, though shown not to have 
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an intrinsic effect on lysozyme resistance, has enhanced significantly the effect of O-acetylation on 
lysozyme resistance in S. aureus (Benkerroum, 2008). One such modification is the presence of acetyl 
moieties at the C-6 hydroxyl group of N-acetylmuramyl residues and some species of eubacteria, 
including some important human pathogens, such as Neisseria gonorrhoeae, Proteus mirabilis, and 
Staphylococcus aureus, which are known to possess O-acetylated peptidoglycan (Clarke & Dupont, 
1992). O-acetylation of peptidoglycan occurs at the C-6 hydroxyl group of N-acetylmuramyl residues, 
producing corresponding 2, 6-diacetylmuramyl derivatives. The extent of naturally occurring O-
acetylation in microorganisms range between < 10 and 70%, while a spontaneous mutant of Micrococcus 
luteus, cultured in the presence of HEWL, has been reported to have a molar ratio of  1:1 for N-
acetylmuramic acid and O-acetyl, respectively. However, the role of O-acetylation in conferring resistance 
to the hydrolytic activity of HEWL was discerned soon after the initial discovery of the modification. 
Subsequent studies have confirmed the resistance of most muramidase to O-acetylated peptidoglycan; 
however, it should be noted that the efficacy of others, such as the N, O-diacetylmuramidases of 
Chalaropsis and Streptomyces globisporus, is not affected by O-acetyl groups, rather its role in resistance 
to muramidase exists (Clarke & Dupont, 1992).  
Moreover, as with other types of modifications to peptidoglycan, the chloramphenicol-induced increase 
in the degree of 6-O-acetylation of the N. gonorrhoeae PG was observed to immediately follow the 
cessation of protein synthesis; this subsequent acetylation was limited to newly incorporated PG. 
Therefore, while the process of O-acetylation occurs outside the cytoplasm, it would appear that it is 
regulated by agents that act directly on cytoplasmic targets. Of therapeutic concern, the increased 6-O-
acetyl content of cell walls in bacteria that are treated with this antibiotic serve to increase its resistance to 
lysozyme (Clarke & Dupont, 1992).  
To overcome the killing action of lysozyme, bacteria have developed different mechanisms, among 
which some have been well dissected. Further, these are mainly based on the modification of the PG 
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structure (Le Jeune et. al., 2010). There is still a need for further investigation to explore mechanisms of 
lysozyme resistance to improve the use of lysozyme in therapeutics. 
1.3.2.4 Inhibitory Activity of Lysozyme Against Microorganisms Other than Bacteria 
To date, no clear explanation has been provided for the sensitivity of some viruses to lysozyme. Cisani 
suggested that the inhibition of the herpes virus is due to interference with antiviral activity because of the 
basic nature of lysozyme, rather than to the hydrolytic activity (Cisani et. al., 1984). Moreover, in vitro 
inhibition of human immunodeficiency virus (HIV) by lysozyme was attributed to the hydrolysis of viral 
polysaccharides and RNA transcripts, or genomic RNA. Therefore, lysozyme may not always act by its 
hydrolytic activity; however, it could inhibit the growth of some microorganisms either by permeabilizing 
the plasma membrane or acting on intracellular components by virtue of its cationic hydrophobic nature, 
as has been described for a variety of antimicrobial peptides. In fact, sublethal concentrations (10 µg/ml) 
of lysozyme were shown to accumulate in the cytoplasm of Candida albicans and reduce the production 
and activity of aspartic proteinase, a putative virulence factor of yeast. This finding indicates that 
lysozyme acts at the transcriptional or translational level of DNA expression and, while at high 
concentrations, it induces a cell-swelling and invaginations near bud scars. This suggests that interference 
with the synthesis of cell-wall components may be alternative targets for this enzyme (Benkerroum, 
2008). Further research is needed to develop a clearer understanding of the mechanism of action by which 
lysozyme acts against sensitive microorganisms in general, and eukaryotic and non-cellular 
microorganisms in particular. 
1.4. Lysozyme Detection 
The need for a gentle method to lyse a particular mechanism is common to many areas of research in 
microbiology; however, a few examples of those procedures with a gentle procedure for removing or 
weakening the cell wall have best initiated (Chassy & Giuffrida, 1980). Numerous methods have been 
reported for the determination of lysozyme. A traditional method was reported in 1946, in which an 
Ostwald or Uberlohde’s viscometer was employed in the determination of lysozyme by monitoring the 
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decrease in viscosity of various substrates (Song and Hou, 2003). Until now, the most widely used method 
was chromatography involving HPLC and affinity chromatography. Furthermore, the nephelometric 
immunoassay has also been developed and has a detection limit of 0.58 mg/ml for assay of lysozyme. In 
addition, several other useful methods have been proposed, including fluorimetry and acoustic wave 
viscosity sensor and response surface methodology (Song and Hou, 2003). 
1.4.1 Factors Influencing Lysis Efficiency 
A number of factors that influence lysis (lysozyme activity) efficiency have been discussed in other 
studies. Specifically, increases in the amount of lysozyme used were not particularly effective in 
increasing extent of lysis; however, it was found that lengthening the period of incubation improved lysis. 
Another factor that is likely to produce a large change in lysis efficiency is the growth medium. 
Researchers found that supplementation of the growth medium with L-threonine, L-lysine, or both, 
usually produced streptococci or lactobacilli cells that were more easily lysed. The action of threonine can 
be explained by its known interference in the establishment of cell wall cross-links. The mode of action of 
L-lysine is more difficult to explain and it is obvious that the composition of the growth medium can 
affect the susceptibility of bacteria to lysozyme; therefore, it should be evaluated with strains that are 
difficult to lyse (Chassy & Giuffrida, 1980). In addition, the choice of buffers is likely a major factor in 
determining the success of many attempted lysis experiments. Other studies have relied on higher pH 
values, higher buffer concentrations, or phosphate buffers. Thus, the use of NaCl, MgCl2, other salts, or 
chelating anions should be avoided because these additives appear to interfere with the lysis of Gram-
positive, asporogenous bacteria. Finally, another factor that contributes to the effectiveness is that the 
enzymatic stabilizer polyethylene glycol (PEG) appears to have more value as a stimulant of lysis than as 
an osmotic stabilizer (Chassy & Giuffrida, 1980). 
1.4.2 Agar Plate Bioassays 
The lysoplate method, Fleming’s second experiment, has also been used as the basis for assay 
development. However, Fleming’s experiments were more complex than the methods used today. Fleming 
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began by boring a well into the agar in a petri dish. A mixture of molten agar and nasal secretions 
containing lysozyme were added to the wells and a second layer of agar was applied, covering the whole 
plate. The top layer of agar was then inoculated with a layer of M. luteus bacteria and incubated for 24 
hours. Fleming’s experiment showed that lysozyme was able to diffuse through the agar and prevent 
growth of the bacteria (Fleming & Allison, 1922). Osserman et. al. (1966) showed that Fleming’s 
lysoplate technique still worked even when simplified. In his experiments the agar was mixed with heat 
killed inactivated bacteria so that it appeared turbid; the agar was allowed to solidify and then wells were 
bored into it. Lysozyme samples were added to these wells and allowed to diffuse over 12-18 hours. The 
observed zone of turbidity clearing is proportional to the concentration of lysozyme (Osserman & Lawlor, 
1966). A big advantage of using this method is its simplicity. Very little training is required to complete 
the test in a clinical environment. 
Similarly, the measurement of lysozyme activity by agar plate bioassay with Micrococcus lutues cells, 
as a test strain, is an indicator test that has been used with many other studies. Enzyme-action produced a 
clear zone with diameters that were proportional to the catalytic activities of the enzyme (Bower, Xu, & 
McGuire, 1998), by growth inhibition of M. luteus on the plate. Therefore, the lysozyme enzyme is found 
to be active on M. lutues cells, which prevented their growth on assay plates (Akinalp et. al., 2007). 
Therefore, the use of agar plate bioassays is a quick and efficient method for screening of initial lysozyme 
activity. 
1.4.3 Activity in Media Measurements (Turbidimetric) 
  Fleming’s turbidimetric assay is the first foundation for the turbidimetric assay of lysozyme. His assay 
is founded on a clearing phenomenon, which is based on preparing a bacterial suspension and followed by 
the addition of lysozyme sample. The rate of optical density reduction was measured to determine the 
lysozyme content of the lysozyme sample (Ronan et. al., 1975). Many of the turbidimetric methods used 
are relatively similar and differ only with respect to the lysozyme activity and sample preparation. These 
differences might include buffer composition, pH, ionic strength, concentration of M. luteus substrate, 
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temperature, duration of incubation and preparation of enzyme (Houser, 1983). In example of this method, 
M. lutues cells were dissolved in phosphate buffer (e.g. 0.01 M; pH 7.3) to give a stable suspension with 
an optical density of 0.9 at 450 nm. The activity of the lysozyme sample was determined by the decrease 
in turbidity of the Micrococcus suspension (at 450 nm) using a spectrophotometer. In this study, for each 
activity assay, 100 µl of T4L (0.5 mg/ml) was added to 3.0 ml of substrate and the decrease in optical 
density (absorbance) was recorded every 0.1 s for 60 s (Bower et. al., 1998).  
Moreover, in a review of turbidimetric studies, Klass et. al. (1977) described the turbidimetric 
technique as having a high sensitivity and a rapid turnover rate; each sample took only one minute to 
process. The Klass et. al. (1977) method has a detection limit of 1 µg/ml whereas the Ronan et. al. (1975) 
method has a detection limit of 1.5 mg/ml (Klass et. al., 1977; Ronan et. al. 1975). The Klass et. al. 
method is the preferred method for routine testing of clinical samples because it has time effective; yet, it 
is not the most reliable as it produces a high inter-batch variability of results, with a precision of 2.5% as 
was obtained by Gorin et. al. (1971). Gorin actually did not look favourably on this precision as they 
compared their data with that of Bergmeyer (1965), who achieved a higher rate of precision. As well, the 
study by Gorin et. al. (1971) also showed that not all commercially available lysozyme substrates (e.g. 
lyophilised M. luteus from Sigma, Calbiochem etc.) produce the same effects, even though they are 
labeled M. luteus. It is important to note that different companies produce different preparations of the 
bacteria, giving varying degrees of clearing rates, with a reported difference of up to 30%, as shown in 
this study. This is caused by the various physical and chemical treatments to which they subject their 
bacteria, which consequently alters the vulnerability of M. luteus to lysozyme and ultimately leads to 
unreliable results for the diagnosis of diseases. Regardless of its unreliability, this assay is easy to 
perform, requires small sample volumes, can be used with serum, urine and tears and is sensitive (Gorin 
et. al., 1971; Bergmeyer, 1965).  
Also, in 1971 Terry et. al. published work using an automated turbidimetric assay. This assay involved 
the use of two colorimeters, which correct the urine and serum discoloration problems experienced with 
  
CHAPTER I                                                                                                                    INTRODUCTION 
25  
controls (causing turbid solutions for blank samples). The bacterial suspension and clinical samples were 
continuously stirred and standards were run simultaneously. This automated assay was able to process 20 
samples per hour and had an increased (yet undisclosed) sensitivity (Terry et. al., 1971). Furthermore, a 
method built on the principles of the turbidimetric assay was devised by Caballero et. al. (1999). 
Cabellero described a micro-particle enhanced nephelometric immunoassay using serum and urine patient 
samples. This assay involved the use of polystyrene particles covalently bound with anti-lysozyme 
antibodies. The polystyrene particles formed larger particles due to the binding with free lysozyme in the 
sample, which resulted in scattered light. The scattered light at the start of the reaction was compared with 
that at the end and used to calculate the lysozyme concentration in the patient sample. The assay detection 
limit was 0.58 mg/l. However, even with this assay Caballero recognized there was still room for 
improvement due to the long incubation periods, need for biological fluid pre-treatment and poor 
detection limit (Caballero et. al., 1999). 
Finally, a commercial assay currently on the market that employs the principle of turbidimetric assays 
is the EnzChek® Lysozyme by Molecular Probes (Leiden, Netherlands). This test measures lysozyme in 
solution at levels as low as 20 U/ml (equivalent to <0.5 µg/ml). The assay measures lysozyme activity 
using M. luteus cell walls on substrate. The bacterial cell walls are specially labeled with a fluorophore in 
such a way that the fluorescence is quenched. Thus, activated lysozyme reduces the quenching while 
increasing the fluorescence. The fluorescence therefore is proportional to the lysozyme activity. The 
increase in fluorescence is measured using a spectrofluorometer, mini fluorometer or a fluorescence 
microplate reader. Each assay takes around 30 minutes with less than an hour preparation time. The assay 
lays claim to being “simple and sensitive” 
(https://tools.invitrogen.com/content/sfs/manuals/mp22013.pdf).  
1.4.4 Thermostability of Lysozyme on SDS-PAGE 
To determine the thermostability of lysozyme enzymes, Akinalp et. al. (2007) tested the supernatant of 
recombinant bacteria by exposing it to various temperatures (from 37°C to 100°C) for 15 min before 
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centrifugation at 15,000 rpm to remove denatured proteins. Then supernatant was mixed with an equal 
volume of trichloroacetic acid and the protein was collected by centrifugation. Following, protein analysis 
was performed using a denaturing polyacrylamide gel (SDS-PAGE, 12% (w/v)). After electrophoresis, 
protein bands were visualized by a coomassie blue staining procedure (Akinalp et. al., 2007). The 
thermostability of these enzymes from the recombinant bacteria was also found to differ from each other. 
In this study, lysozyme expressed by S. salivarius subsp. thermophilus cells seemed to increase its 
capacity for thermoresistance and was not denatured at 70°C for 15 min. In contrast, the enzyme 
expressed by L. lactis and E. coli cells was easily denatured when exposed to the same temperature 
treatment (Akinalp et. al., 2007). 
1.4.5. Immunoassays 
Researchers have raised great concern for the lack of sensitivity and lengthy performance times of 
Fleming’s turbidimetric and lysoplate techniques; thus, immunoassays may offer an important alternative 
to the determination of lysozyme by addressing some of these issues. Immunoassays rely on the reaction 
between the target analyte and a specific binding molecule of biological decent (the antibody). They can 
produce both quantitative and qualitative results and have shown considerable improvements in sensitivity 
(Ekins & Chu, 1997). For example, Porstmann et. al. (1989) developed an enzyme immunoassay for the 
detection of lysozyme in patients with Crohn’s disease and rheumatoid arthritis. Urine samples were taken 
from patients and were tested using three variations of the same method. The method showing highest 
sensitivity involved pre-coating a microtitre plate with anti-lysozyme IgG overnight at 4˚C, followed by 
two hours incubation at room temperature with the clinical sample and IgG-HRP (Horseradish 
Peroxidase) conjugate. Then, the assay was stopped by addition of o-henylenediamine with 15 minutes 
incubation. The detection limit for this assay was 0.2 µg/l (Porstmann et. al. 1989). 
Moreover, Francina et al. (1986) reported an immunoassay developed to test lysozyme secretion in 
serum of acute myeloid leukemia patients. A microtitre plate was incubated at 4˚C overnight with anti-
lysozyme IgG. After a wash, the plate was then incubated for one hour at 37˚C with the clinical sample. 
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Consecutively, biotinylated antilysozyme was added and the plate was again incubated for one hour 
further. After, the plate was washed and incubated with avidin peroxidase solution for 10 minutes at room 
temperature. This assay was stopped by the addition of enzyme substrate for five minutes incubation. The 
total assay time was ~14.5 hours. To reduce assay time the two one-hour incubations were reduced to 20 
minutes and the enzyme substrate incubation to five minutes, yet the total assay time was still over 12 
hours. The detection limit for the standard assay was 0.1 ng/ml and for the rapid assay 1 ng/ml (Francina 
et. al., 1986). In another example, Taylor et. al. (1992) also present an immunoassay for the detection of 
lysozyme. This test was developed to measure lysozyme in healthy adult’s serum and urine samples. The 
method involved pre-coating a microtitre plate with rabbit anti-human lysozyme, followed by addition of 
the clinical sample and incubation for 90 minutes at room temperature. Additionally, a conjugated sheep 
anti-human lysozyme was added and incubated for a further 90 minutes at room temperature. Finally, 
enzyme substrate p-nitrophenyl sodium phosphate was added and incubated for 30 minutes at room 
temperature. The total assay time was 15 hours and the detection limit was 1 µg/litre (Taylor et. al., 1992). 
As well, some immunoassay kits are available on the market and include the Human Lysozyme EIA kit 
from Biomedical Technologies Inc. (Stoughton, USA). Referred to as sandwich ELISA, this method 
detects lysozyme from serum, plasma, urine, tears and saliva, where the reference value for human 
lysozyme from serum ranges from 3-10 µg/ml. In this assay, specific lysozyme antibodies bound to 
polystyrene wells were incubated with a sample and a second human lysozyme-specific antibody is then 
added; as well as a horseradish peroxidase conjugated secondary antibody. The total test time is 4 ¼ hours 
(http://www.funakoshi.co.jp/data/datasheet/BTI/BT-630.pdf).  
Similarly, the company Orgentec (Mainz, Germany) supplies a kit known as Anti-lysozyme kit for 
lysozyme in serum and plasma. This test only requires 10 µl of patients’ sample and involves a plate pre-
coated with antibody. The antigen from patients’ sample is added along with a horseradish peroxidase 
conjugate; followed by TMB (a color substrate). The reaction is stopped using Hydrochloric acid and the 
total time for this assay is two hours, due to the plates being purchased pre-coated. During this time 96 
  
CHAPTER I                                                                                                                    INTRODUCTION 
28  
patient samples can be processed 
(http://www.orgentec.com/products/pdfs/ELISA_en_IFU_ORG_526.pdf). All these kits have the 
advantage of conducting analysis on several patient samples using minimal biological fluid. This not only 
alleviates discomfort and distress to patients, but also the costs to lab facilities. 
1.4.6. Biosensor  
Biosensor and related bioarray techniques represent the end product of a rapidly growing field, which 
combines fundamental biological, chemical, and physical sciences with engineering and computer science 
to satisfy needs in a broad range of application areas. Not surprisingly, the term biosensor has different 
connotations depending on the field. For example, to the biologist, a biosensor is a device that translates 
biological variables (e.g., electric potentials, movement, or chemical concentrations) into electrical 
signals. To the chemist, a definition might be a device that uses specific biochemical reactions as mediated 
by isolated enzymes, immunosystems, tissues, organelles, or whole cells to detect chemical compounds, 
usually by electrical, thermal, or optical signals. While, the physicist might define a biosensor as a device 
that detects, records, and transmits information about a physiological change or process (Marks et. al., 
2007). Together, biosensor can be defined as an analytical device that converts the concentration of the 
target substances, the analyte, into an electrical signal via a combination of biological or biologically-
derived recognition systems, either integrated within or intimately associated with a suitable physico-
chemical transducer. Basically, biosensors consist of three parts including recognition, transducer, and 
signal output. A biological sensing element with a transducer will produce a signal that is proportional to 
target analyses. When biological molecules interact with target analyses, there is change in one or more 
physical-chemical parameters that are associated with the interaction such as generation of ions, gases, 
electrons, heat, or mass. The quantities of these indicating signals are converted into electrical signals 
(Figure 2).  
In addition, biological or biologically-derived elements are capable of recognizing the presence, 
activity, or concentration of a specific target analyte in a complex mixture of components. The recognition 
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element may comprise one of three different types: affinity biosensors (based on ligand-receptor 
interactions such as those involving antibodies, nucleic acid, aptamers, peptides, protein, or cell receptor); 
binding and catalysis (involves enzymes, microorganisms, organelles, plant or animal cells or tissue 
slices); biomimetic receptors (based on various synthetic binding or catalytic systems). The interaction, or 
subsequent reaction, of the recognition element with the analyte in a sample matrix results in a reactant or 
formation of a product that is immediately proximal to the transducer. The latter converts the change in 
solution property into a quantifiable and processable electrical signal. The transducer is a device, usually 
electronic, electroacoustic, electro-optical, electromagnetic, electrothermal, or electromechanical, that 
converts one type of energy (electricity, sound, light, magnetism, heat, or mechanical) into another 
(usually electrical) for various purposes including measurement or information transfer (Marks et. al., 
2007). More research is needed to develop an electrochemical approach for the detection of lysozyme; 
such biosensor development will offer an alternative, sensitive, and versatile method for protein detection. 
Currently, most proteins are detected mostly by antibodies in analytical formats like ELISA, immunobead 
assay, western blotting, and microarrays.  
1.4.7 Flow injection Chemiluminescence System  
A novel analytical procedure, based on chemiluminescence (CL) detection, was described for the 
determination of lysozyme at ng/ml level using controlled-reagent-release technology in a flow injection 
system. The analytical reagents involved in the CL reaction, including luminol and periodate, were 
immobilized on the anion-exchange resins in the flow injection system. Through water injection, luminol 
and periodate were eluted from the anion-exchange column to generate the chemiluminescence, which 
was inhibited in the presence of lysozyme. By measuring the decrease of CL intensity, one could analyze 
the lysozyme concentration in the range of 30-100 ng/ml (Figure 3). A typical analytical procedure, which 
includes sampling and washing, could be performed in 0.5 min at a flow rate of 2.0 ml/min, giving a 
throughput of 120 h with a relative standard deviation of less than 3.0%. The proposed method was 
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applied successfully to the determination of lysozyme in human tear and saliva samples and recovery was 
from 92.0% to 105.7% (Song and Hou, 2003). 
F1 chemiluminescence (CL) analysis is becoming increasingly important in various fields because of 
its high sensitivity, rapidity, simplicity and feasibility. The fast oxidation reaction between luminol and 
periodate in alkaline medium produces a strong CL signal. Further, CL is greatly inhibited by lysozyme; 
thus, a sensitive CL inhibition assay for lysozyme combined with F1 technology was described in that 
paper (Figure 4). The proposed method offered simple and cheap instrumentation and rapid and 
reproducible means of detection; that was demonstrated in its application to determine lysozyme in human 
tear and saliva (Song and Hou, 2003). Within that work, a sensitive and convenient analytical method, 
using control-reagent-release technology in flow injection system, was developed to determine lysozyme 
in human tears and saliva by its inhibitory effect on CL. In addition, incorporation of the immobilized 
reagents column into the flow injection analysis (FIA) manifold offers satisfactory stability, good 
reproducibility, and precision in the analysis (Song and Hou, 2003). 
Thesis objectives 
T4L, the most active lysozyme in sterilization, constitutes a natural defense mechanism. In addition to 
its anti-bacterial action, lysozyme may have anti-tumor, anti-metastatic, and anti-inflammatory activities 
in the medical field. Also, it has some industrial application usages including: food-processing, food 
packing, wine maturation, infant formulas and baby foods, and enhancing plant resistance to diseases. To 
date, there has been no T4L industrialization globally. This success of such technology development in 
this thesis study will facilitate the production of recombinant T4L for industrialization purposes. 
The principal goal of this study was to express a synthetic t4l in two microorganism hosts, which are E. 
coli and T. reesei. That was through sequential steps in this study, first studying synthetic t4l in 
bioinformatics level by comparing it to wild-type T4L. Second, transforming three plasmids-bearing-
synthetic t4l into E. coli, then producing a novel strain of T. reesei, followed by optimizing culture 
conditions of transformants in order to enhance the production of recombinant T4L, and evaluation of 
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target gene expression of transformants. To accomplish that primary goal, there were several specific 
objectives generated and classified accordingly into each chapter. 
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Tables: 
Table 1 Main chemical properties of milk lysozymes of different mammals: chicken egg-white lysozyme properties are also 
given as a reference for the c-type lysozyme, (Benkerroum, 2008). 
Origin MW (kDa) Folding properties Catalytic center residues Reference 
Camel milk 14.4 NA NA El Agamy et al. (1996) 
Cow milk 14.4 Two-state Glu35 Asp53 El Agamy et al. (2000) 
Ewe milk 16.2 Two-state Glu53 Asp21 Maroni et Cuccuri, (2001) 
Human 15 Two-state --- Parry et al. (1960) 
Goat 14.4 Two-state Glu35 Asp53 Jolles et al. (1990) 
Buffalo 16.0 Two-state NA El Agamy (2000) 
Mare 14.7 Three-state Glu35 Asp53 Jauregui-adell (1974); Sarwar et al. (2001) 
Canine 14.5 Three-state Glu35 Asp53 Grobler et al. (1994) 
Egg-white 14.3 Two-state Glu35 Asp52 Matagne and Dobson, (1998) 
Table 2 Reported concentrations (mg/l) of lysozyme in the milk of different mammals, (Benkerroum, 2008) 
Animal Species Average concentration References 
Human 
400 
320 
270-890 
224-426 
Mathur  et al. (1990) 
Montagne et al. (1998) 
Montagne et al. (2001) and Chandan et al. (1968) 
Hennart et al. (2004) 
Ass  1428 Salimei et al. (2004) 
Mare  790  1330 
Jauregui-Adell (1975) 
Sarwar et al. (2001) 
Cow 
0.13 
0.07 
0.05 – 0.21 
Chandan et al. (1968) 
El Agamy et al. (1996) 
Piccinni et al. (2005) 
Buffalo 0.0012 Priyadarshini and Kansal (2003) 
Ewe  0.1  Chandan et al. (1968) 
Goat 0.25 Chandan et al. (1968) 
Sow  6.8 Schultz and Müller (1980) 
Camel  0.15 El Agmay et al. (1996) 
Table 3 Application area, antimicrobial agents and packaging materials used in antimicrobial food packaging (Source: Han 
2000, Appendini and Hotchkiss 2002). 
Antimicrobial Agent Packaging Material Application area 
Lysozyme LDPE* Bell pepper LDPE Cheese 
* LDPE: low-density polyethylene; 
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Chapter II: Computational Analysis of T4 Lysozyme 
Abstract  
The field of bioinformatics has experienced explosive growth in the last decade, in both the field of 
bioinformatics and computational biology; two T4L genes that have been studied are the wild-type and 
synthetic one. The later, new synthetic t4l was produced by codon-based modification with alternation of 
triplet nucleotides that encodes two specific amino acid residues at position 6 and 12 in a polypeptide 
chain of T4L protein. The goal of constructing synthetic t4l was to enhance the production of recombinant 
T4L for industrialization purposes after its successful expression in the host. Therefore, comparison of the 
wild-type and synthetic t4l from nucleotide sequences up to 3D protein structure was unavoidable. 
Bioinformatics tools are used to identify the nucleotide sequences and their protein products, identify 
homologous sequences, structural information, and analyze the quality of the structures. Also, different 
programs, web servers, and parameters are used as bioinformatics tools. Likewise, experimentally derived 
3D proteins’ structures have been studied in detail.  
Wild-type and synthetic t4l have variants in the size of nucleotides, 459 bp and 491 bp, respectively, 
but both have equal amino acids size, 164 a.a. The results of the multiple sequence alignment indicate 
both amino acids sequences have high fully conserved residues to their sequence similarity obtained from 
the database. In addition, the conserved motifs were high with wild-type t4l as well the synthetic one; just 
one out of seven had a slight difference for position-specific score matrix with T4LYSOZYME1 motif in 
our study. The comparison of 3D protein structure showed us how both protein structures have structural 
similarity by calculating RSMD; 0.17 for the backbone coordinate and 0.14 for the carbon alpha 
coordinate. Also, structure sequence identity was 98.87% by using the alignment of editor Jalview. In 
conclusion, wild-type and synthetic T4L supposedly share the same function of hydrolysis, yet there is 
variability at position 6 and 12 in amino acids sequence. 
Key words: Bioinformatics, Wild type and Synthetic T4 Lysozyme, 
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2.1. Introduction 
Phage T4 is considered one of the most structurally complex viruses. It is a linear double-stranded 
DNA (dsDNA) tailed virus with a genome that contains 274 open reading frames (ORFs) out of which 
more than 40 encode structural proteins. The structures of phage T4 head, tail, and fibres have been well 
studied. Subsequently, a structural model of phage T4 has been determined. The advances in electron 
microscopy, X-ray crystallography, and computing power have extended the structural knowledge of T4 
to higher resolution (Leiman et. al., 2003). Phage T4 has been used as an important model system in the 
development of modern genetics and molecular biology since the 1940s. The advantages of phage T4 as a 
model system stemmed in part from the virus’ total inhibition of host gene expression, which allows 
investigators to differentiate between host and phage macromolecular syntheses. Phage T4 also produces 
some important enzymes with widespread commercial applications, including its DNA and RNA ligase, 
polynucleotide kinase, and DNA polymerase. Many would argue that to know phage T4 is to know the 
foundations of molecular biology and the essential paradigms of genetics and gene expression (Miller et. 
al., 2003). 
Structurally, phage T4 has a chromosome surrounded by a capsid that is attached to a tail structure; all 
are composed of phage-encoded proteins. The phage genome encodes most of the gene products needed 
for replicating more phages. It has a 172 kb linear double-stranded DNA genome (Trun & Trempy, 2004). 
Additionally, by the early 1990s, much of the genome had been sequenced, but extensive regions 
remained intractable. However, the complete 168,903-bp sequence of the T4 genome is now available on 
the NCBI Genome website (http://www.ncbi.nlm.nih.gov/Entrez), under GenBank accession no. 
AF158101 and/or entry NC_000866 (Miller et al., 2003).  
In molecular biology, glycoside hydrolase family 24 is a family of glycoside hydrolases EC 3.2.1. a 
widespread group of enzymes that hydrolyse the glycosidic bond between two or more carbohydrates, or 
between a carbohydrate and a non-carbohydrate moiety. A classification system for glycoside hydrolases, 
based on sequence similarity, has led to the definition of a number of different families (Henrissat, 1991; 
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Henrissat & Bairoch, 1993;!Henrissat & Bairoch, 1996). This classification is available on the CAZy 
website (http://www.cazy.org/Glycoside-Hydrolases.html) (Henrissat and Coutinho, 2011), and also 
discussed at the CAZypedia website, which is an online encyclopaedia of carbohydrate active enzymes 
(http://www.cazypedia.org/index.php/Main_Page). Moreover, the glycoside hydrolase family 24 (GH24) 
comprises enzymes with only one known activity that is hydrolysis. This family includes E. coli 
endolysin, lambda phage lysozyme, as well as T4L (Weaver & Matthews, 1987). E. coli endolysin 
functions in bacterial cell lysis and acts as a transglycosylase, while lysozyme helps to release mature 
phage particles from the cell wall by breaking down the peptidoglycan of prokaryotic cell walls. 
Specifically, T4L structure contains two domains, the interface between which forms the active-site cleft. 
The N-terminus of the two domains undergoes a “hinge-bending” motion about an axis passing through 
the molecular waist (Weaver & Matthews, 1987; Faber & Matthews, 1990). This mobility is thought to be 
important in allowing access of substrates to the enzyme active site.  
Currently, molecular biological data are being produced at an unexpected rate. A flood of data means 
that many of the challenges in biology are now challenges in computing. Thus, the use of techniques from 
applied mathematics, informatics, statistics and computer sciences to solve biological problems has 
created the bioinformatics field (Luscombe et. al., 2001). In fact, several new fields within molecular 
genetics have been created, such as bioinformatics, genomics, and proteomics. Each of these fields 
integrates the use of computer hardware and software to store, process and analyze biological information, 
such as DNA or protein sequences (Elrod & Stansfield, 2010). Therefore, bioinformatics could be defined 
as the application of computational techniques to understand and organize the information associated with 
biological molecules. The three main aims of bioinformatics involve: firstly, the simplest organization of 
data in such a way that allows scientific researchers to access existing information and to submit new 
entries as they are produced. Secondly, bioinformatics requires development of tools and resources to aid 
in the analysis of those data. Thirdly, these tools analyze the data and interpret the results in a biologically 
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meaningful manner (Luscombe et. al., 2001). Therefore, correlation of these aims extends the purpose of 
bioinformatics much further. 
More specifically, the field of bioinformatics relies heavily on Linux-based computers and program 
software, which is a free operating system (OS) for computers. While most bioinformatics programs can 
be run on Mac OS X and Windows systems, it is often more convenient to install and use the software on 
a Linux system. And for most Linux users, the simplest way to access a Linux system is by connecting 
from their primary Mac OS X or Windows machine. This type of arrangement allows several users to run 
software on a single Linux system, which can be maintained by an experienced systems administrator. In 
addition, Linux users should be familiar with some basic commands (Stothard, 2011), because it is the 
only language for communication with this system.  
Furthermore, Virtual Network Computing (VNC) is remote control computer software, which allows 
the user to view and fully interact with one VNC server using a simple VNC viewer on another computer 
desktop anywhere on the Internet. Additionally, it is not a requirement that the two computers be the same 
type. While for ultimate simplicity, there is even a Java viewer, so that any desktop can be controlled 
remotely from within a browser without having to install software. Currently, VNC is in widespread 
active use by many millions of people throughout industry, academia and privately. There are also several 
versions from which to choose, including a free version and some substantially enhanced commercial 
versions (Sasa, 2012).  
Here, studying wild-type and synthetic t4l genes is crucial to genetic and protein modifications, by 
means of bioinformatics. While the genetic modification on synthetic t4l was highly sensitive and specific, 
comparison to its wild-type bioinformatically might be essential for a desired expression. The comparison 
between these two t4l genes has been studied on a bioinformatics level, starting from their nucleotide 
sequences up to three-dimensional (3D) protein structures. Generally in this section of the thesis project, 
nucleotide and amino acid, conserved and non-conserved motifs, and 3D structures of T4L were analyzed 
by different popular bioinformatics software.  
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2.1.1. Approach
Two nucleotide sequences identify the genetic sequence of a particular protein, T4L, they have been 
assigned by sequential steps. Firstly, a gene sequence corresponding to wild-type and synthetic t4l genes 
was retrieved, using the NCBI genome browser for the former, while the latter was already known. Also, 
search for synthetic t4l gene sequence was important to determine whether there is any previous published 
research work using the synthetic t4l in this study yet. Subsequently, the nucleotide sequence is translated 
into amino acid sequence, and then the obtained protein is reported. Next, a database similarity search is 
run using BLAST for amino acid sequences. Then, a multiple sequence alignment is performed using the 
amino acid sequence file built as mentioned above. There are many reasons to construct a multiple 
sequence alignment, including highlighting regions of similarity, divergence and mutations. This is done 
by describing regions/positions as either conserved or variable. Later, a specific database server was used 
to search for conserved motifs in the protein sequence. Then, those motifs sequences determined where 
they hit in the synthetic T4L amino acid sequence. The next step is to find out if wild-type and synthetic 
t4l proteins have three-dimensional (3D) protein structures available in the Protein Data Bank (PDB). If 
any of those proteins do not have experimentally determined 3D structure, one can be created through the 
use of a modeling web. The protein 3D structure is required to build a graphical representation and get an 
image file; that is to analyze protein structures and discuss the overall quality of both structures.  
2.2. Methodology 
2.2.1 VNC Software 
This applied project familiarizes one with the computer environment, basic Linux commands and 
fundamental molecular biology. Furthermore, VNC software, housing the “Advanced Bioinformatics” 
course, has been used throughout this study. This system allowed several connections (VNC Viewer 
Software) to the same desktop (VNC Server Software), providing an invaluable tool for collaborative or 
shared working through secure logon into the Internet. However, VNC server address and password is not 
provided. Finally, all projects’ reports are created in electronic form only. 
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2.2.2. Exhaustive comparison between two versions of T4 lysozyme 
2.2.2.1. Retrieving nucleotide and amino acid sequence  
To begin, genetic sequences for wild-type t4l were obtained. Specifically, the National Center for 
Biotechnology Information (NCBI) website (http://www.ncbi.nlm.nih.gov/) was used to acquire the 
nucleotide sequence of wild-type t4l; “T4 Lysozyme” was the search query. From the results list, “e 
intracellular N-acetyl muramidase; lysis from within [Enterobacteria phage T4]” was chosen as 
corresponding to wild-type t4l. Also from the same entry page, the link “Nucleotide” under “Links” on the 
right side of the window was selected; from that results list “Enterobacteria phage T4, complete genome” 
was chosen. Enterobacteria phage T4 linear DNA size is 168,903 bp with accession no. NC_000866.4 
and/or GI 29366675. Then, gene with location complement (66503..66997) was clicked on, which is gene 
“e” (its locus tag is “T4p123” and GeneID 1258585); nucleotide sequence was obtained by scrolling down 
to the feature table, denoted by the “FEATURES” key in the left-hand column on the window. Following, 
the nucleotide sequence was obtained in FASTA format, by selecting FASTA. Next, under “All Links 
from this record,” “Protein” then “e Lysozyme murein hydrolase [Enterobacteria phage T4]” were 
selected to get protein translation of coding regions from sequence records in the current set. Protein size 
was 164 a.a.; accession no. NP_049736.1 and/or GI 9632737. The protein sequence in FASTA format was 
acquired and saved, by selecting FASTA.  
Moreover, since synthetic T4L nucleotide sequence was known; BLAST algorithm at NCBI 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) was used directly to run a database similarity for that gene. The 
first-best matched under alignments of query was “Synthetic T4 Lysozyme gene, complete cds,” with 
accession no. GI: M18375.1; it has linear DNA with 518 bp and has been selected as an alternative for our 
synthetic t4l for preliminary steps. Then, protein-coding sequence (CDS) 24..514 region was selected and 
represented Lysozyme. Next, the new window was for synthetic T4L gene, complete cds, and its size, 495 
bp, the nucleotide sequence of which was obtained in FASTA format, by selecting FASTA. Thus, this 
nucleotide sequence was considered the most similar sequence to our synthetic t4l in the NCBI database, 
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which can be used for the initial steps. In addition, this protein size was 164 aa; with protein ID 
AAA72629. The protein sequence was obtained in FASTA format, by selecting the FASTA link. 
2.2.2.2. Database similarity and multiple sequence alignment 
BLAST algorithm at NCBI was used to compare a database similarity for “e Lysozyme murein 
hydrolase [Enterobacteria phage T4]” amino acid sequence, which was selected to represent wild-type 
T4L, to all other sequences in database. This was done by clicking the “protein blast” link, followed by 
pasting amino acid sequence in the query sequence textbox. Also, “Non-redundant protein sequences (nr)” 
under “Database” and “blastp (protein-protein BLAST)” under “Algorithm” were selected before running 
the BLAST. The ten best-matched homologous proteins under alignments of query were recorded. 
Subsequently, ten selected homologs amino acid sequences were used in addition to the original amino 
acid sequence to create multiple sequence alignments. Regions of similarity, divergence and mutations 
were highlighted using Clustalx application with BLOSUM 30 for substitution matrices. Then, conserved 
and non-conserved positions were determined. Also, the percentages of identities between the original 
amino acid sequence and each additional sequence in the alignment clarified distantly related members of 
a family and the evolution of the target sequence. Similarly, BLAST algorithm at NCBI was used again to 
run a database similarity for the obtained amino acid sequence, which is “Synthetic T4 Lysozyme gene, 
complete cds,” to all sequences in a database, using the same approach as with wild-type T4L nucleotide 
sequence. The ten first-best matched under alignments of query were recorded. 
Nevertheless, translating our synthetic T4L nucleotide sequence into a protein was required to perform 
a multiple sequence alignment and along with further steps. Thus, jemboss application of European 
Molecular Biology Open Software Suite (EMBOSS) package was used for the gene nucleotide sequence 
to be translated to amino acid sequence. First, Open Reading Frames (ORFs) were identified using Plot 
Potential Open Reading Frames (PLOTORF). F1 frame was the longest ORF with 498 nucleotides. 
Thereafter, Finds and Extracts Open Reading Frames (GETORF) option was used to translate that area 
obtained from PLOTORF. Therefore, numbers 7 and 498 were start codon and stop codon, respectively. 
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Also, amino acid sequence of synthetic t4l was acquired in FASTA format. Then, the sequence of that 
region determined above was translated using Translate Nucleotide Acid Sequence (TRANSEQ) with 
parameters derived from results of previous steps, to get the exact amino acid sequence of synthetic t4l in 
FASTA format. Furthermore, the amino acid sequence obtained was compared using GETORF with the 
amino acid sequence of Lysozyme [synthetic constructed], and using BLAST algorithm at NCBI, an 
identity of 99% (162/164) was found. Additionally, freak application, reads nucleotide sequences and 
generates the used GC nucleotide frequency, and the output was in plot.  
All amino acid sequences of synthetic t4l plus 10 selected homologs amino acid sequences were used 
to create multiple sequence alignments. Then, the Clustalx application was applied again using BLOSUM 
30 for substitution matrices. Also, conserved and non-conserved positions were determined. Finally, the 
percentages of identities between synthetic t4l and the other sequence in the alignment clarified distantly 
related members of a family and the evolution of the target sequence.  
2.2.2.3. Motifs profile 
While “e Lysozyme murein hydrolase [Enterobacteria phage T4]” protein with accession no. 
NP_049736.1 on NCBI is represented in the wild-type T4L protein, scanning its sequence has permitted 
exploration of its motifs and the search for conserved motifs in the sequence. Therefore, Expert Protein 
Analysis System (ExPASy) proteomic server of the Swiss Institute Bioinformatics (SIB) database 
(http://expasy.org/) was used to find out whether wild-type T4L has an entry on ExPASy or not. From that 
server, Protein Knowledgedatabase (UniProtKB) was selected and accession no. NP_049736.1 was used 
as the inquiry search. However, only “P00720” accession no. for T4L protein was found in that database. 
Consequently, the link “PR00684” under the section “Family and domain databases” / “PRINTS” block 
was selected to determine the number of motifs in this protein structure along with recording the sequence 
of each motif to find their exact location within the wild-ype T4L amino acid sequence (Table 7). The 
number of motifs and their sequences were obtained using wild-type T4L protein and thus, they are 
  
CHAPTER II                                                                                                                  METHODOLOGY 
47  
already known; therefore, the search for the sequence of each motif was recorded to find their location in 
the synthetic t4l amino acid sequence. Finally, recording how well they are conserved was reported.  
2.2.2.4. Analyzing protein 3D structure 
The 3D protein structure of the wild-type T4L is required to study the protein structure. Thus, Protein 
Data Bank (PDB), a member of the Research Collaboratory for Structural Bioinformatics (RCSB) 
(http://www.rcsb.org/pdb/home/home.do), was explored to find out the 3D protein structure. “Phage T4 
lysozyme” was the query search and 2LZM as PDB ID was selected for this protein, because it was the 
only entry mentioned in its Molecular Description “P00720” entry for UniProtKB. Then, the structure in 
PDB format was downloaded along with its experimental details.  
First, Visual Molecular Dynamics (VMD) software was used to visualize the protein structure by 
creating graphical representations and determining the number of alpha helix and beta-strand regions. 
Different models were generated with graphic representation. Also, looking at the amino acid sequence of 
wild-type T4L protein structure was achieved using Sequence Viewer option with the same software that 
determined the number of alpha helix regions (marked as pink-purple blocks) and beta-strand regions 
(represented as yellow blocks).  
However, there was no entry in any database for synthetic t4l. Therefore, there was no experimentally 
determined 3D protein structure for it in RCSB PDB. One of the ExPASy tools used to create a model for 
synthetic t4l protein was the Tertiary structure-Homology modeling-Automated homology modeling 
program using neural networks (ESyPred3D) 
(http://www.fundp.ac.be/sciences/biologie/urbm/bioinfo/esypred/). This modeling web server requires the 
protein sequence and 3D protein structure to be used as template. A 3D model of that protein sequence 
was built using the 3D wild-type lysozyme protein structure (PBD ID 2LZM) as template as was selected 
before, which shared 98.8% identities with the sequence query (using the align program). Also, the 
structure of protein in PDB format was downloaded with no experimental details. Then finally, the protein 
structure was visualized using VMD and graphical representations created.  
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2.2.3. Comparison of T4 lysozyme 3D protein structures 
The comparison of wild-type and synthetic T4L proteins’ structures was also done using VMD 
software. This was accomplished by performing structural alignment and calculating Root Mean Sequence 
Deviation (RSMD). RSMD measures the average distance between the atoms of superimposed proteins, 
which makes a quantitative comparison between the structure of the target protein and the structure of 
native state. A structural alignment was performed using Multiple Alignment application. Backbone, all-
atoms, and carbon alpha coordinators were calculated and reported after superposition of the two 3D 
protein structures. In addition, the output of multiple alignments read with alignment editor Jalview in 
jemboss package. This was to calculate the percentage of sequence identity, which was obtained from 
those 3D protein structures, with pairwise alignment.  
2.3. Results and Discussion 
2.3.1. Retrieving nucleotide sequence and protein translation 
Based on NCBI search, wild-type t4l is represented on “e intracellular N-acetyl muramidase; lysis from 
within [Enterobacteria phage T4]” entry. Some information related to this entry is summarized in Table 1. 
The size of the gene code is 459 bp: linear DNA. This sequence was the starting point for the study of 
wild-type t4l; the nucleotide sequence in FASTA format is shown in Figure 1-A. Moreover, using NCBI, 
protein translation of coding regions of wild-type T4L has been acquired; its accession number is 
NP_049736. The protein is made up of 164 a.a. The rest of the studies all depend on this protein sequence, 
making it important; also, the protein sequence in FASTA format is shown in Figure 1-B. In comparison, 
based on BLAST algorithm at NCBI search, the best matched under alignments for the synthetic t4l 
nucleotide sequence was “synthetic T4 lysozyme gene, complete cds.” Information related to this 
selection is summarized in Table 2. As well, the size of this code is 495 bp, linear DNA for Lysozyme; 
CDS 24..514 region selected represented Lysozyme. The nucleotide sequence in FASTA format is shown 
in Figure 2-A. Finally, on NCBI protein translation of coding regions of Lysozyme [synthetic construct] 
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protein sequence was obtained; it is made up of 164 a.a. and with accession no. AAA72629. The protein 
sequence in FASTA format is shown in Figure 2-B.  
2.3.2. Protein database similarities and multiple sequence alignment 
Protein database similarity was performed for wild-type T4L amino acid sequence. The ten first best-
matched amino acid sequences similarity are recorded along with their organism name, score, E-value and 
percentage of identity and similarity to search inquiry, using BLAST algorithm at NCBI (Table 3). All 
those sequences were also related to bacteriophage T4 organism, and thus, required performance of a 
multiple sequence alignment for them. Additionally, wild-type T4L amino acid sequence and amino acid 
sequences greater than the ten first best-matched were used to perform a multiple sequence alignment, 
using Clustalx application. From the Clustalx result, there were two non-conserved, six strongly 
conserved, and 156 fully conserved positions identified with the position of residues (Table 4). Also, 
Clustalx gave 98% percentage of identities between wild-type T4L and each individual sequence of the 
ten first best-matched amino acid sequences (Table 5. A). Similarly, using BLAST algorithm at NCBI the 
ten first matched of “Lysozyme [synthetic construct]” amino acid sequence similarity were recorded along 
with their organism name, score, E-value and percentage of identity and similarity to search inquiry 
(Table 4). However, the amino acid sequence for synthetic T4L required performance of multiple 
sequence alignments. 
2.3.2.1 EMBOSS package analysis 
Firstly, F1 frame had the longest ORFs using PLOTORF application; this allowed a rapid visual 
overview of the distribution of ORFs in the six frames of our synthetic T4L sequence (Figure 3). As well, 
there are 498 nucleotides. Thereafter, the GETORF application was used for the translation of region 
between 7 and 498 codons (Figure 4 A). Then identification of ORFs and the start and end nucleotide 
positions; the TRANSEQ application identified a protein coding region (Figure 4 B). Moreover, the 
comparison between the TRANSEQ result and the translation of “Lysozyme [synthetic constructed]” 
sequence was done using BLAST algorithm at NCBI, resulting in 99% (162/164) identity. In addition, the 
  
CHAPTER II                                                                                           RESULTS AND DISCUSSIONS 
50  
plot result of freak application showed the G+C nucleotides frequency of wild-type and synthetic T4L 
DNA molecules; either guanine (G) or cytosine (C). Basically, the GC pair is bound by three hydrogen 
bonds, while AT pairs are bound by two hydrogen bonds. DNA with high GC-content is more stable than 
DNA with low GC-content; however, the hydrogen bonds do not stabilize the DNA significantly, and 
stabilization is due mainly to stacking interactions. Consequently, in PCR experiments the GC-content of 
primers is used to predict their annealing temperature to the template DNA. A higher GC-content level 
indicates a higher melting temperature, and this was used for considerations in the following study (Figure 
5). Our synthetic T4L amino acid sequence plus the ten first best-matched amino acid sequences were 
used to perform a multiple sequence alignment using the Clustalx application. From the Clustalx results, 
there are two non-conserved, five strongly conserved, and 157 fully conserved positions identified in the 
multiple sequence alignment (Table 5). Also, Clustalx gave the percentage of identities of 98% between 
our synthetic T4L and the other sequence in alignment (Table 6). 
2.3.3. Motifs analysis 
To begin, the pattern of domain of T4L is not found in the ExPASy server; however, in the PRINTS 
server there are seven motifs within T4L protein structure. Therefore, the sequence of those seven motifs 
was recorded and determined to be in the T4L amino acid sequence using Motifs Search tool of 
GenomeNet (http://www.genome.jp/tools/motif/), along with position-specific score matrix for each motif 
(Table 8). The PRINTS is a compendium of protein motif fingerprints. While, a fingerprint is a group of 
conserved motifs used to characterize a protein family. During the search of each entry in the database, a 
set of blocks (simple fingerprints) is converted to a position-specific score matrix (profile). This matrix is 
then used to score the motif found in the query sequence. Consecutively, the motif blocks in the PRINTS 
database are calibrated based on the distribution of matches determined in a search as described by the 
authors. Each raw score is divided by an estimated score of 99.5% of true negative sequence and 
multiplied by 1000. Thus, a derived score of 1000 infers that match would be at the 99.5% false matches, 
which means scores less than and around 1000 are probably not important. 
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Likewise, synthetic T4L does not have an entry in the ExPASy server. Therefore, the determined seven 
motifs of wild-type T4L amino acid have been applied to the synthetic one. Also, the sequences of those 
seven motifs have been determined in the synthetic T4L amino acid sequence using the same application 
that was used with wild-type T4L protein (Table 8). After comparing the score results of found motifs, 
one of seven motifs had an insignificant difference with score results, which was T4LYSOZYME1 motif. 
The difference was inversely related to the modification made to the synthetic T4L nucleotide. In other 
words, there were two single residues replaced into the same protein motif fingerprint as follows: M6 
(Methionine at position 6) in wild-type was replaced by K6 (Lysine) in synthetic one. Also, G12 (Glycine 
at position 12) in wild-type was substituted by R12 (Arginine) in the synthetic one, and that both 
alterations developed changing the score from 1265 with wild-type to 1227 with synthetic T4L protein. 
Additionally, the two amino acids in wild-type T4L protein have nonpolar properties and were replaced 
with two basic properties, according to amino acids properties.  
2.3.4. Analyzing T4 lysozyme 3D protein structure 
Protein Data Bank (PDB) ID 2LZM is a representation of T4L 3D protein structure; described as 
“Structure of bacteriophage T4L refined at 1.7 angstroms resolution.” It is related to bacteriophage T4 and 
classified as a hydrolase. Additionally, the X-ray diffraction experimental method for it is 1.7 Å 
resolution. This 3D structure will assist comparison and analysis of the synthetic T4L 3D protein 
structure. Thus, a graphic representation using VMD software was created to visualize the different 
chemical structure of T4L 3D protein structure to ultimately understand more about it. While using 
NewCartoon as Drawing Method and ResType as Coloring Method, the amino acid residues were 
coloured according to their chemical character, such as white for hydrophobic, green for polar uncharged, 
red for negatively charged, and blue for positively charged. Then, the sequence viewer application 
determined two regions for alpha helix and two regions for beta-strand in this protein. Again, synthetic 
T4L is a constructed gene and has no entry in any database. A model for synthetic T4L was created based 
on PDB ID 2LZM as a template for wild-type T4L protein structure using the ESyPred3D server. This 
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template shares 98.8% identities with the sequence query (using the align program); however, there is no 
experimental detail provided from the server.  
2.3.5. Comparison of T4 lysozyme 3D protein structures 
The wild-type and synthetic T4L share sequence homology; nevertheless, a residue at position 12 
indicated variable conserved status based on multiple sequence alignment results for both wild-type and 
synthetic T4L amino acids sequence. Also, the residue at position 6 was fully conserved in wild-type yet 
variable with synthetic T4L amino acid sequence. Therefore, the Sequence Viewer application with VMD 
software was applied to generate amino acid sequences from 3D protein structures of wild-type and 
synthetic T4L; then the generated amino acid sequences were aligned to obtain their sequence homology. 
The results showed there were two altered amino acid residues at positions 6 and 12 with synthetic T4L 
protein (Figure 6); confirming the previous finding.  
Moreover, comparison of both proteins’ structures determined how structurally similar they are. After 
the superposition of 3D protein structures, the reported backbone using RSMD for synthetic T4L 
compared to wild-type was 0.17. In addition, carbon alpha and all-atoms of RSMD were 0.14 and 5.80, 
respectively, concluding they are close together structurally. Also, the sequence identity of both structures 
was 98.78%, as determined using the alignment editor Jalview in jemboss package. Finally, based on all 
the information related to both RSMD and amino acid sequence, the two altered amino acid residues 
(M6èK6, G12èR12) were labeled using VMD software for each 3D protein structure, wild-type and 
synthetic (Figure 7).  
Conclusion 
In this study, we confirmed that there was no published study that used our synthetic T4L gene, which 
has been previously worked on. Wild-type and synthetic T4L have variation in the size of nucleotides, 459 
bp and 491bp, respectively; however, both have the same amino acid size of 164 a.a. Additionally, the 
results of multiple sequence alignments indicate both amino acids sequences have high fully conserved 
residues in their sequences similarity obtained from the database. Most of the sequences similarities 
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obtained from the database are related to Enterobacteria phage T4 and their percentage of identity to target 
sequences is high, at approximately 98%. Therefore, more studies are needed for the evolution of T4L. 
Moreover, the conserved motifs were high with wild-type T4L as well the synthetic; one out of seven had 
an insignificant difference in the score results, which was T4LYSOZYME1 motif, in this study. Also, the 
comparison of 3D protein structure exhibited how both protein structures have structural similarity 
through the calculation of RSMD; 0.17 for backbone coordinate and 0.14 for carbon alpha coordinate. As 
well, structure sequence identity was 98.87% using the alignment of editor Jalview. In conclusion, wild-
type and synthetic T4L supposedly share the same function of hydrolysis, yet there is variability at 
position 6 and 12 in amino acids sequence. 
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Figure 8 
Figure 5: EMBOSS-freak plot results, for wild type (A) and synthetic T4L nucleotide sequence (B) 
A 
B 
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Table: 
Table 1: General Information about wild type t4l, from NCBI 
Table 4  
Gene ID 1258585 
Gene Description Intracellular N-acetyl muramidase; lysis from within 
Locus tag T4p124 
Gene type Protein coding 
RefSeq status Provisional 
Organism Enterobacteria phage T4 
Lineage Viruses; dsDNA viruses, no RNA stage; Caudovirales; Myoviridae; T4-like viruses 
 
Table 2: General Information of gene represented synthetic T4L 
Table 5 
Length 518 
Score 342 bites (378) 
E-value 2e-90 
Identification 375 / 499 (76%) 
Gape 0 / 499 (0%) 
Accession  M18375 
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Table 3: Sequence produce significant alignment 
Table 6 
No Accession Description Total Score 
Query 
coverage 
E 
value 
1 NP_049736.1 
e Lysozyme murein hydrolase [Enterobacteria phage T4] 
>gb|AAD42568.1|AF158101_155 e Lysozyme murein hydrolase 
[Enterobacteria phage T4] >emb|CAA28212.1| unnamed protein product 
[Enterobacteria phage T4] 
340 100% 4e-92 
2 P00720.1 RecName: Full=Lysozyme; AltName: Full=Endolysin; AltName: Full=Lysis protein; AltName: Full=Muramidase Bacteriophage T4 Lysozyme  334 100% 2e-90 
3 1L17_A Chain A, Hydrophobic Stabilization In T4 Lysozyme Determined Directly By Multiple Substitutions Of Ile 3 333 100% 3e-90 
4 1DYC_A Chain A, Determination Of Alpha-Helix Propensity Within The Context Of A Folded Protein: Sites 44 And 131 In Bacteriophage T4 Lysozyme 333 100% 4e-90 
5 1L14_A Chain A, Contributions Of Hydrogen Bonds Of Thr 157 To The Thermodynamic Stability Of Phage T4 Lysozyme 333 100% 4e-90 
6 1L52_A Chain A, Structural And Thermodynamic Analysis Of The Packing Of Two Alpha-Helices In Bacteriophage T4 Lysozyme 333 100% 4e-90 
7 3C7W_A Chain A, Contributions Of All 20 Amino Acids At Site 96 To The Stability And Structure Of T4 Lysozyme 333 100% 5e-90 
8 149L_A Chain A, Conservation Of Solvent-Binding Sites In 10 Crystal Forms Of T4 Lysozyme 333 100% 5e-90 
9 1DYF_A Chain A, Determination Of Alpha-Helix Propensity Within The Context Of A Folded Protein: Sites 44 And 131 In Bacteriophage T4 Lysozyme 333 100% 6e-90 
10 1DYD_A Chain A, Determination Of Alpha-Helix Propensity Within The Context Of A Folded Protein: Sites 44 And 131 In Bacteriophage T4 Lysozyme 333 100% 6e-90 
11 1L38_A Chain A, Contributions Of Engineered Surface Salt Bridges To The Stability Of T4 Lysozyme Determined By Directed Mutagenesis 333 100% 6e-90 
 
Table 7 
No Accession Description Total Score 
Query 
coverage 
E 
value 
1 P00720.1 RecName: Full=Lysozyme; AltName: Full=Endolysin; AltName: Full=Lysis protein; AltName: Full=Muramidase Bacteriophage T4 Lysozyme  340 100% 3e-92 
2 1L17_A Chain A, Hydrophobic Stabilization In T4 Lysozyme Determined Directly By Multiple Substitutions Of Ile 3 340 100% 4e-92 
3 1DYC_A Chain A, Determination Of Alpha-Helix Propensity Within The Context Of A Folded Protein: Sites 44 And 131 In Bacteriophage T4 Lysozyme 340 100% 4e-92 
4 1L14_A Chain A, Contributions Of Hydrogen Bonds Of Thr 157 To The Thermodynamic Stability Of Phage T4 Lysozyme 340 100% 5e-92 
5 1L52_A Chain A, Structural And Thermodynamic Analysis Of The Packing Of Two Alpha-Helices In Bacteriophage T4 Lysozyme 340 100% 5e-92 
6 3C7W_A Chain A, Contributions Of All 20 Amino Acids At Site 96 To The Stability And Structure Of T4 Lysozyme 339 100% 6e-92 
7 1DYF_A Chain A, Determination Of Alpha-Helix Propensity Within The Context Of A Folded Protein: Sites 44 And 131 In Bacteriophage T4 Lysozyme 339 100% 7e-92 
8 149L_A Chain A, Conservation Of Solvent-Binding Sites In 10 Crystal Forms Of T4 Lysozyme 339 100% 7e-92 
9 1DYD_A Chain A, Determination Of Alpha-Helix Propensity Within The Context Of A Folded Protein: Sites 44 And 131 In Bacteriophage T4 Lysozyme 339 100% 7e-92 
10 1L33_A Chain A, Contributions Of Left-Handed Helical Residues To The Structure And Stability Of Bacteriophage T4 Lysozyme 339 100% 8e-92 
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Table 4: Result of multiple sequence alignment (MSA) for wild type T4L amino acid sequences compared to its 10 selected 
amino acid similarity and result of MSA for synthetic T4L amino acid. 
Table 8 
Amino Acid  Conserved Status with Position of residue(s) Variable  Strongly Fully 
WT T4L  12, 137 96, 123, 131, 152, 157 (1-11), (13-95), (97-122), (124-130), (132-136), (138-151), (153-156), (158-164) 
Synthetic T4L  6, 12 3, 96, 131, 152, 157 1, 2, 4, 5, (7-11), (13-95), (97-130), (132-151), (153-156), (158-164) 
 
Table 5: Percentage of identity to wild type (a) and synthetic T4L (b) by Clustalx 
(a) 
Table 9 
No. Sequence identify by organisms name % Identity 
1 Enterobacteria phage T4 (Bacteriophage T4) 100 
2 Enterobacteria phage T4  98 
3 Enterobacteria phage T4  98 
4 Enterobacteria phage T4  98 
5 Enterobacteria phage T4  98 
6 Enterobacteria phage T4  98 
7 Enterobacteria phage T4  98 
8 Enterobacteria phage T4  98 
9 Enterobacteria phage T4  98 
10 Enterobacteria phage T4  98 
 (b) 
No. Sequence identify by organisms name % Identity 
1 Synthetic T4 Lysozyme (constructed gene) 100 
2 Synthetic construct 98 
3 Enterobacteria phage T4  98 
4 Enterobacteria phage T4  98 
5 Enterobacteria phage T4  98 
6 Enterobacteria phage T4  98 
7 Enterobacteria phage T4  98 
8 Enterobacteria phage T4  98 
9 Enterobacteria phage T4  98 
10 Enterobacteria phage T4  98 
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Table 6: Sequences of seven motifs included in wild type T4L protein 
Table 10 
Motifs Motifs sequence 
T4LYSOZYME1 FEMLRIDEGLRLKIYKDTEG 
T4LYSOZYME2 YYTIGIGHLLTKSPSLNAA 
T4LYSOZYME3 GRNCNGVITKDEAEKLFNQD 
T4LYSOZYME4 DAAVRGILRNAKLKPVYDSLD 
T4LYSOZYME5 RRCALINMVFQMGETGVAGF 
T4LYSOZYME6 LRMLQQKRWDEAAVNLAKSR 
T4LYSOZYME7 WYNQTPNRAKRVITTFRTGTWD 
Table 7: Sequence of seven motifs determined in wild type and synthetic T4L protein with position, sequence, score, and 
description 
Table 11 
Protein Motif Position Sequence Score Description 
W
ild
 T
yp
e 
T4
L 
T4LYSOZYME1 4..23 FEMLRIDEGLRLKIYKDTEG 1280 Phage T4 lysozyme signature 
T4LYSOZYME2 24..42 YYTIGIGHLLTKSPSLNAA 1278 Phage T4 lysozyme signature 
T4LYSOZYME3 51..70 GRNCNGVITKDEAEKLFNQD 1301 Phage T4 lysozyme signature 
T4LYSOZYME4 72..92 DAAVRGILRNAKLKPVYDSLD 1322 Phage T4 lysozyme signature 
T4LYSOZYME5 95..114 RRCALINMVFQMGETGVAGF 1301 Phage T4 lysozyme signature 
T4LYSOZYME6 118..137 LQQKRWDEAAVNLAKSI 1265 Phage T4 lysozyme signature 
T4LYSOZYME7 138..159 WYNQTPNRAKRVITTFRTGTWD 1342 Phage T4 lysozyme signature 
Sy
nt
he
tic
 T
4L
 T4LYSOZYME1 4..23 FEKLRIDERLRLKIYKDTEG 1227 Phage T4 lysozyme signature 
T4LYSOZYME2 24..42 YYTIGIGHLLTKSPSLNAA 1278 Phage T4 lysozyme signature 
T4LYSOZYME3 51..70 GRNCNGVITKDEAEKLFNQD 1301 Phage T4 lysozyme signature 
T4LYSOZYME4 72..92 DAAVRGILRNAKLKPVYDSLD 1322 Phage T4 lysozyme signature 
T4LYSOZYME5 95..114 RRCALINMVFQMGETGVAGF 1301 Phage T4 lysozyme signature 
T4LYSOZYME6 118..137 LRMLQQKRWDEAAVNLAKSR 1265 Phage T4 lysozyme signature 
T4LYSOZYME7 138..159 WYNQTPNRAKRVITTFRTGTWD 1342 Phage T4 lysozyme signature 
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Chapter III: Expression of a Synthetic T4 Lysozyme Gene in Escherichia coli 
Abstract 
Although T4L enzyme is similar to HEWL, T4L is considered the most active lysozyme in 
sterilization. In this study, developed T4L gene with codon-based modification has been cloned into three 
vectors with different promoters for expression in a select strain of Escherichia coli. Briefly, expression of 
synthetic t4l was done by transforming three separate plasmids-bearing-synthetic t4l into two strains of E. 
coli, JM109 and BL21(DE3)pLysS. Using the agar halo assay, the later was tested for its sensitivity and/or 
resistance to the lysis action of lysozyme enzyme before the transformation-took place. Following the 
optimization of culture conditions for transformants; conventional PCR was used to detect and amplify the 
synthetic t4l gene cloned into the plasmids. Also, SDS-PAGE assay demonstrated that the recombinant 
T4L was expressed in all three transformants of E. coli, which named as BST4, BLT4, and BPT4, after 
breaking bacterial cell wall by sonication. In conclusion, resistance of BL21(DE3)pLysS strain to 
lysozyme activity was confirmed with our halo assays, which show this strain is a good choice for 
expression of this lysis enzyme. Also, the results of PCR showed that the synthetic t4l was successfully 
transformed into selected E. coli strain. Furthermore, the expression of that gene was shown on SDS-
PAGE assay with an apparent molecular mass of approximately 18 kDa. However, characterization and 
measurement the recombinant T4L production still requires more research. 
Key words: E. coli, T4 Lysozyme, PCR, SDS-PAGE
3.1. Introduction 
Bacteriophage is a bacterial virus, it invades and controls bacterial metabolism, then terminates its 
incubation through bacterial lysis, as is the case with lytic phages (Sulakvelidze et. al., 2001). One type of 
bacteriophage is bacteriophage T4 (also it is called phage T4), which infects the bacterial cell. Moreover, 
upon infecting a bacterium and producing progeny phage T4 only undergoes lytic growth (Trun & 
Trempy, 2004). Unlike animal viruses, infection of host cells by tailed phage is highly efficient because 
only one phage T4 particle is adequate for initial infection process. Additionally, upon infection the phage 
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shuts down host-specific nucleic acid and protein syntheses, thus ensuring sole production of its own 
components in amounts sufficient to assemble up to 200 progeny virus particles per infected cell (Leiman 
et. al., 2003).  
In more detail, an insertion of T4 DNA into bacterium follows four steps; first phage T4 initiates 
infection of a susceptible bacterium by recognizing the lipopolysaccharide cell surface receptors with the 
distal ends of its long tail fibers (LTFs). Subsequently, the short tail fibers (STFs) unravel from 
underneath the baseplate and bind irreversibly to the lipopolysaccharide cell surface receptors, thus 
securely anchoring the baseplate to the cell membrane. Meanwhile, the baseplate changes its conformation 
from hexagonal to star-shaped, causing contraction of the tail sheath. Then the tail sheath contacts, driving 
the internal tail tube through the peptidoglycan-containing outer membrane. After, T4L is secreted to 
digest the cell wall allowing penetration of the tail tube to the inner membrane where the DNA is released 
from the phage head through the tail tube into the host cell. Once T4 DNA is in the cell cytoplasm, it 
initiates replication of its own DNA with a highly organized and coordinated program of gene expression, 
using both replication and recombination (Trun & Trempy, 2004; Leiman et. al., 2003); thereby releasing 
new replicated phage particles. In addition, Phage T4 is one of the most structurally complex virus 
particles known, devoting more than 40% of their genetic information to the synthesis and assembly of the 
prolate icosahedral heads, tails with contractile sheaths, and six tail fibers that contribute to their very high 
efficiency of infection (Miller et. al., 2003).  
T4L, produced by phage T4, is structurally similar to HEWL in its active site and its site of attack on 
the peptidoglycan cell wall (Akinalp et. al., 2007). Moreover, it is a well-characterized protein; its 
molecular weight is approximately 18 kDa. Specifically, it cleaves β-1,4 glycosidic bonds between N-
acetylmuramic acid (NAM) and N-acetylglucosamine (NAG) in the bacterial peptidoglycan (Bower et. 
al., 1998) (Figure 1). Therefore, T4L is said to destroy bacteria by its muramidase activity. However, 
another study demonstrates that the C-terminus of T4L mediates its bactericidal and fungistatic activities. 
For example, in heat-denatured T4L, the enzymatic activity was completely abolished, yet unexpectedly 
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the antimicrobial functions remain preserved. Comparable results were also obtained with HEWL (During 
et. al., 1999 and Dong et. al., 2008). This knowledge opens up many new opportunities for optimization of 
lysozymes as antimicrobial agents in various applications using protein engineering. 
The present study aimed to express a synthetic T4L-encoding gene in select Escherichia coli (E. coli) 
host strains, through the transformation of three plasmids; each bearing-synthetic t4l. Additionally, culture 
conditions were optimized for transformants in order to enhance the production of recombinant T4L. 
3.2. Materials and Methods 
3.2.1. Synthetic T4 Lysozyme Gene 
A synthetic (modified) T4L gene, homologous to wild-type T4L which originated from phage T4, was 
constructed; a generous gift from former labmate Dr. Xi Chen. There were three strategies Dr. Chen 
developed regarding construction of synthetic t4l, which are as follows; first, construction of recombinant 
plasmids where wild-type t4l is controlled by a strong promoter. Secondly, production of new t4l 
sequence using codon bias. Lastly, recombinant T4L production is enhanced through optimization of the 
transformant culture conditions. Specifically, the synthetic t4l is 510 base pair (bp) in size (Figure 2). 
Moreover, the synthetic gene was cloned into three different vectors along with different promoters. The 
three vectors bearing-synthetic t4l are named as follows: QS, QL, and T4L-pET-20b (+) (Figure 3). QS 
and QL vectors are 9,000 bp in size; plus, they contained CbhI promoter from Trichoderm reesei 
cellobiohydrolases I gene, which facilitates the transcription of synthetic t4l in T. reesei,  to be discussed 
in the following study. However, the main difference between QS and QL vectors is in the signal peptide 
size; QS has 15 amino acids (a.a), while QL has 30 a.a. The third vector T4L -pET-20b(+), was 4,096 bp 
in size. It contains a T7 promoter that only binds T7 RNA polymerase and was designed with the pET 
expression system. Both promoters allow for manipulation of the quantity of expressed desired proteins 
and when the expression occurs.  
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3.2.2. Bacterial Strains and Media 
Two strains of Escherichia coli (E. coli) were used, one for plasmid replication and the other for host 
expression of synthetic t4l, JM1O9 and BL21(DE3)pLysS, respectively. Also, M. luteus was used to test 
lysozyme activity. All strains were grown in Luria-Bertani (LB) broth (10 g/L peptone, 5 g/L yeast 
extract, 5 g/L NaCl), LB agar (same content of LB broth plus 12.8 g/L agar) and Super Optimal Broth 
(SOB) broth (20 g/L peptone, 5 g/L yeast extract, 0.58 g/L NaCl, 0.1875 g/L KCl, 2 g/L MgCl2.6H2O, 2.5 
g/L MgSO4.7H2O, up to 1 L ddH2O) (Maki et. al., 2011; Hanahan, 1983). Additionally, the following 
antibiotics were used where appropriate: 100 µl/ml of ampicillin for growth of JM109, 50 µl/ml of 
ampicillin plus 34 µl/ml of chloramphenicol for growth of BL21(DE3)pLysS; and for selection of 
transformants. No antibiotics were used with the growth of M. luteus.   
3.2.3. Halo Assay for Analysis of Host Strains 
Due to the antimicrobial properties of lysozyme, it was necessary to determine whether E. coli 
BL21(DE3)pLysS strain would be a suitable host for expression; this was done by testing the strain 
against commercial lysozyme on agar plate via a method termed halo assay. Although halo assay is not 
quantitative, it is however, one the most sensitive methods to detect enzymatic activity and is appropriate 
in the present context (Kuroki et. al., 1999). The halo assay procedure was adapted from Pjura et. al., 
(1993) (Pjura et. al., 1993), with minor modifications. Specifically, in this assay a clear circle or halo on 
agar plate represents lysozyme activity during bacterial lawn growth, which varies from one species to 
another. Specifically, M. luteus and E. coli BL21(DE3)pLysS were tested against a commercial lysozyme 
(1 g of stock powder lysozyme, 50 ml of autoclaved 1X TE buffer). E. coli BL21(DE3)pLysS was 
selected because of its specific sensitivity against lysozyme and is considered the optimal substrate for 
studying lysozyme effects (Eggert-Kruse et. al., 2000).  
Briefly, a fresh single colony from M. luteus and E. coli BL21(DE3)pLysS LB agar plates was 
inoculated into a 250ml flask containing 20 ml LB broth individually, incubated at 37°C in shaker with 200 
rpm, overnight. Next day, 200 µl of each bacterial culture was spread-plated on fresh LB agar with 
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appropriate antibiotics if necessary, using a sterile glass spreader. Prior to spread-plates, the optical density 
at 600 nm (O.D.600nm) for M. luteus and E. coli BL21(DE3)pLysS, were adjusted to 0.9 O.D. 600nm. 
Thereafter, plates were allowed to dry for approximately 30 min at room temperature. Then, on each plate 
four drops with varying volumes and concentrations of 20 µg/ml commercial lysozyme stock were added 
onto each quarter of the agar plate to optimize results, as follows: 2 µl, 5 µl of 0X; 5 µl of 10X; 5 µl of 
100X. Once again, the plates were dried, then inverted and incubated at 37°C overnight. The following 
day, agar plates were visualized and photographed for halo analysis. 
3.2.4. Electrotransformation of E. coli JM109 and BL21(DE3)pLysS  
Electrocompetent cells of E. coli were prepared according to the method described by Majeed et. al., 
(2011) (Majeed et. al., 2011). Briefly, fresh single colony of E. coli JM109 and BL21(DE3)pLysS were 
individually inoculated into a flask containing 50 ml of LB broth and incubated at 37˚C, shaking at 200 
rpm overnight. Next day, 1 L of pre-warmed LB broth was inoculated by the overnight bacterial culture 
and once again incubated on a rotary shaker at the same conditions. Consequently, growth of bacterial 
cultures was measured at O.D.600nm every 30 min. Then, once the O.D.600nm of the cultures reached 
approximately 0.6 (+/- 0.2), the flasks were immediately transferred to an ice-water bath for 30 min, with 
occasional swirling. After, cultures were transferred to ice-cold centrifuge bottles and the cells were 
harvested by centrifugation at 6000 rpm for 30 min, at 4˚C. Then, supernatant was discarded and sterile 
cold deionised and distilled H2O (ddH2O) was added to the same volume; followed by centrifugation at 
5000 rpm for 10 min, at 4˚C. The latter step was repeated twice to wash each strain. Similarly, the 
supernatant was decanted and the cell pellet resuspended first in 250 ml then in 10 ml of sterilized ice-cold 
10% glycerol twice as previously described for sterile cold ddH2O. Next, the supernatant was carefully 
decanted; then, the pellet was resuspended in 1 to 2 ml of sterile ice-cold 10% glycerol and aliquoted into 
40 µl tubes.  
Moreover, the three plasmids; QS, QL, and T4L-pET-20b(+) bearing synthetic t4l, were independently 
electrotransoformed into competent cells of E. coli JM109 then BL21(DE3)pLysS strains by 
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electroporation technique according to Dower et. al., (1988) (Dower et. al., 1988). In brief, 40 µl of 
freshly made electrocompetent cells were pre-chilled, along with 0.2 cm gap electroporation cuvettes on 
ice. Also, 1 – 2 µl of each plasmid DNA, ranging in concentration from 2 to 7 µg, was pre-mixed with 
chilled electrocompetent cells and incubated on ice for 30 – 60 seconds. Rapidly, DNA/cell mixture was 
pipetted into a chilled electroporation cuvettes. Next, a pulse of electricity was delivered to the cells using 
Gene Pulser XcellTM microbial system (Bio-Rad Laboratories, Richmond, CA), with 2 mm / 2.5 kV. 
Immediately thereafter, the electroporation cuvette was removed and 1 ml of SOB medium added at room 
temperature; then transferred to 1.5 ml microfuge tube and incubated 1 hour at 37˚C, shaking at 50 rpm. 
Following, 200 µl of electroporated cells were spread plated onto the surface of LB agar plates, including 
appropriate antibiotics (100 µl/ml of ampicillin for JM109, 50 µl/ml of ampicillin plus 34 µl/ml of 
chloramphenicol for BL21(DE3)pLysS). All plates were incubated at 37˚C; transformed colonies 
appeared in ~ 18 hours of the incubation period and were then streaked out on separate LB plates to ensure 
the purity (Figure 4).  
Furthermore, the plasmid DNA was extracted from transformants using GeneJETTM Plasmid Miniprep 
Kit (Fermentas), according to the supplier’s protocol. The DNA samples were run on 1% agarose gel; gels 
were then examined under UV illumination to observe extracted plasmid DNA.  
3.2.5. PCR Amplification of Synthetic t4l 
Detection and PCR amplification was performed to confirm the presence of synthetic t4l in the 
extracted plasmid DNA from transformants E. coli JM109 and BL21(DE3)pLysS (Snounou et. al., 1993). 
The following primers were used to amplify a PCR product of 510 b.p. from synthetic t4l gene in the 
vectors: “T4L-Primer 5” (Forward (FW): 5`-TCC CAT ATG AAC ATC TTC GAG AAG TTG AGA-3`) 
and “T4L- Primer 6” (Reverse (REV) 5`-ATA CTC GAG CAA GTT CTT GTA AGC GTC CCA-3`). 
Oligonucleotides were designed on the basis of the known DNA sequences of the synthetic t4l using 
DNAMAN software version 7.212 (Lynnon Corporation, Canada) and custom-synthesized by Eurofins 
MWG Operon, Canada. The PCR reaction mixtures was performed using 20 µl in 0.2 ml of PCR tubes 
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consisting of 6.6 µl of Master-mix, which included 4 µl 5X Phusion HF buffer (BioLab), 0.4 µl 10 mM 
dNTPs, 1 µl of each 10 pmol forward and reserve primers, and 0.2 µl Phusion High-Fidelity DNA 
polymerase (BioLab), 1.5 µl of (10 ng) extracted plasmid DNA as template and 5.3 µl of sterile UV-
treated ddH2O. The PCR was reaction was run in MyCycler thermal cycler (BIO-RAD) according to the 
following protocol: primary denaturation 5 minutes at 95˚C, followed by 30 amplification cycles 
consisting of denaturing at 94˚C for 1 minute, annealing for 1 minute at 60˚C, and extension at 72˚C for 1 
minute, upon completion of 30 amplification cycles a final extension step was done at 72˚C for 10 
minutes. Finally the reaction was held at 4˚C. The PCR products were visualized by 1% agarose gel 
electrophoresis stained with ethidium bromide for visual detection on an UV transillumination. Gels were 
then examined under UV illumination and photographed to confirm size, quantity and purity. 
3.2.6. Expression of T4 Lysozyme from Transformants and SDS-PAGE 
To produce recombinant T4L, transformants BL21(DE3)pLysS carrying three plasmids bearing 
synthetic-t4l-gene were induced by the addition of isopropyl-B-D-thiogalactoside (IPTG) according to the 
method described by Langen et. al, (2000) (Langen et. al., 2000). In the beginning, one fresh single 
colony of each transformants was inoculated in LB broth (5ml) supplemented by 50 µg/ml Ampicilin and 
34 µg/ml Chloramphenicol at 35˚C with 180 rpm in shaker, for overnight. Then, the cultured bacteria (500 
µl) diluted in 50 ml of LB broth. The O.D600 measurements followed until reached 0.5, at that time, 500 µl 
of 0.1 M IPTG (final concentration 1.0 mM IPTG) added to the culture. After incubation for 2-3 hours 
more at 25˚C instead of 37˚C, cells were collected by centrifugation for 10 min at 3,5000 rpm. 
Subsequently, 1 ml of the supernatant collected in microcentrifuge tube and kept in ice, while the rest of 
supernatant was discarded. The pellet resuspended with 0.01 M PBS buffer (pH 7.5) and centrifuge with 
same condition mentioned above for washing. Adding 500 µl of same buffer was before sonicated the 
cells at 70 for 5s and cool down for 2 min intervals, for total of 6 times. Follow that, samples centrifuged 
for 2 min at 15,000 xg, then the supernatant was collected also. Using Sodium Dodecyl Sulfate 
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Polyacrylamide Gel Electrophoresis (SDS-PAGE) with these two collected samples set was for detection 
of the production of recombinant T4L. 
SDS-PAGE has been used to separate proteins according to their electrophoretic mobility. Definitely, 
adjusting the gel concentration based on the molecular weight of protein, in our case, 12% resolving gel 
was used for denaturing SDS-PAGE, while for stacking gel 5%. Also, using tetramethylethylenediamine 
(TEMED) with both gels was essential. TEMED was used with ammonium persulfate (APS) to catalyze 
the polymerization of acrylamide when making polyacrylamide gels. Therefore, after it was added to the 
solution, gel casted right away. Both collected samples set, before and after sonication, was prepared as 
follow: 24 µl of sample mixed with 2 µl of reducing buffer and 10 µl of dye; except the sonicated sample 
has been diluted 1:1 with 0.01 M PBS buffer pH 7.5. After mixing the samples, they were boiled for 5 min 
at 100˚C, before loading 10 µl in the gel. Next, the samples were loaded in the gel followed by attaching 
the power supply, and 80 V was used first for 10 – 20 min, after that, the voltage increased up to 110 V, 
for approximately two hours and half.  
After running an SDS-PAGE gel, gel was washed with dH2O several times gently. Definitely, there are 
several kinds of staining that have been used for staining the SDS-PAGE gel such as, PageBlue, 
Coomassie, and Silver staining. Here, coommassie staining was used by putting the gel in container for 
staining by coomassie blue staining solution and kept in staining solution for 30 min with gentle shaking 
(60 rpm). Then, stained gel was washed with H2O and putted in a clean try and coomassie blue destaining 
solution was added to remove the stain from the gel for overnight. Next day, the gel was washed with H2O 
and gel photographed. The expect band for T4L should has a molecular weight of approximately18 
kilodalton (kDa). 
3.3. Results and Discussions 
3.3.1. Halo Assay 
Growth inhibition of M. luteus was visualized by the appearance of a clear zone after treatment with 
varying concentrations of commercial lysozyme (Figure 5.A). In contrast, there was no lysis activity 
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observed towards E. coli BL21(DE3)pLys growth when the same volume and concentration of 
commercial lysozyme was used (Figure 5.B). Therefore, the results demonstrate that BL21(DE3)pLysS 
strain is a good potential candidate for the expression of recombinant T4L such as synthetic t4l. The exact 
mechanism of lysozyme resistance is not fully understood and may vary according to the bacterial strain 
or species; however, various possibilities have been discussed in other studies such as: O-acetylation of 
the NAM of PG as described for 11 Gram positive and Gram negative species, attachment of other 
polymers. For example, the attachment of polysaccharides to the cell wall, as described for streptococci, a 
high degree of peptide cross-linking, or N-non-substituted glucosamine residues in the peptidoglycan, as 
in Bacillus spp. and Streptococcus pneumonia. However, researchers suggested the resistance of 
BL21(DE3)pLysS is related to OatA gene encoding O-acetyltransferease A. 
3.3.2. Synthetic t4l amplification 
Two primers: T4L-Primer 5 and T4L-Primer 6, were used in combination with PCR to successfully 
amplify the synthetic t4l fragment from extracted plasmid DNA of transformants. A confirmation of the 
amplified synthetic t4l fragment was validated by band on a 1% agarose gel with an approximate size of 
510 b.p., this was the exact size of the gene of interest: synthetic t4l. (Figure 6).    
3.3.3. Detection of Recombinant T4 Lysozyme 
After PCR confirmation of the three plasmids into E. coli BL21(DE3)pLysS, the expression of 
synthetic t4l was examined via the detection of t4l in the medium. Thus, supernatant samples of the 
transformants BL21(DE3)pLysS containing t4l were collected and ran on SDS-PAGE gel. The first set of 
collected samples, without sonication treatment; displayed no significant bands for the presence of 
recombinant T4L. However, the experimental samples, collected after sonication, displayed very clear 
bands for all transformants; while, the negative control (native BL21(DE3)pLysS) did not show a band. 
Based on the ladder, the bands had a molecular weight equivalent to approximately 18 kDa, which is the 
exact molecular weight of T4L (Figure 7). This was an excellent indication of successful expression of the 
synthetic t4l in E. coli system.  
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Conclusions 
The results of this study show E. coli BL21(DE3)pLysS may be good potential candidate for the 
production of T4L as a bioproduct. Moreover, it has been considered for several years, that M. luteus is 
the most lysozyme-action sensitive; thus, it was used in the current study as a test strain. Future work will 
be done on the transformants to optimize T4L external production and evaluate individual T4L activities 
to look for novel recombinant T4Ls. As well, the production of this natural antimicrobial agent in the E. 
coli system is important in industry to help overcome costly hurdles in the sterilization process. In this 
study, all transformants of BL21(DE3)pLysS were found to produce T4Ls and their T4Ls will be further 
studied.  These transformants represent important T4L-producing hosts and may be an integral part of 
future work to develop efficient T4L producing system which can be used for industry. Finally, the 
expression of synthetic t4l in E. coli system, may also contribute to expression of the same gene in other 
microorganism, which are known for producing heterologous proteins.  
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Chapter IV: Expression of T4 Lysozyme gene in Trichoderma reesei 
Abstract  
In this study, Trichoderma reesei QM6a was developed as a host to produce recombinant T4L using 
protoplast-based transformation method. The biological output of T4L in T. reesei strain was done using 
synthetic t4l, which was previously studied through bioinformatics and expression in E. coli cells. 
However, here the exogenous gene of T4L was modified for control in T. reesei expression, using T. 
reesei cellobiohydrolase I (CbhI) gene promoter for induction mode. Thus, specific culture and growth 
conditions could improve the biological output of t4l and its extraction.  
The operon of t4l was cloned into three different plasmids and was successfully integrated in T. reesei 
QM6a strain, to form recombinant strains, termed: ST4L1, ST4L2, and ST4L3. Moreover, the synthetic 
t4l was successfully expressed in two of our recombinant strains, as confirmed by SDS-PAGE. Therefore, 
I developed a novel system by which a foreign gene can be successfully inserted into the chromosome of 
T. reesei, and where transcription can be driven by cbhI promoter, with the addition of the inducer carbon 
source. T4L production by this system was stable and the system may be useful in biotechnological 
fermentation processes other recombinant proteins.  
Key words: T. reesei, T4 Lysozyme, PCR, Sequencing, SDS-PAGE 
4.1. Introduction 
Fungi are nonmotile eukaryotes and their cell wall is usually made of the polysaccharide chitin. Unlike 
animals that ingest then digest their food, fungi are absorptive heterotrophs. That is, they secret 
extracellular enzymes into the environment, then absorb the digested nutrients. Additionally, fungi are 
informally divided into unicellular yeast and filamentous molds based on their reproductive structures; the 
majority of fungi are filamentous; one of them Trichoderma reesei (T. reesei) species, can be found 
hidden underground or within decaying matter (Leboffe & Pierce, 2005). T. reesei, also known as 
Hypocrea jecorina, is widely used in industry for cellulase production (Lorito et. al., 2010). Originally, T. 
reesei QM6a strain was isolated from the Solomon islands in World War II because of its degradation of 
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canvases and garments of the US army (Seidl et. al., 2009). More specifically, the T. reesei haploid 
genome is estimated at 33 Mb, organized in 7 chromosomes, comprised of 9,120 genes targeting 9,115 
proteins (Chambergo FS et. al., 2002; Martinez D et. al., 2008). This fungus represents an ideal model 
system to study the regulation of plant cell wall degrading enzymes, which play an important role in the 
conversion of cellulosic biomass into glucose, which is then fermented to bioethanol by yeast (Seidl et. 
al., 2009). T. reesei produces a variety of extracellular enzymes, like cellulases and hemicellulases that 
hydrolyse plant-derived polysaccharides into monomeric sugars, which in turn are used as a source of 
carbon and energy by the fungal cells. Also, the cellulolytic system of the fungus secretes several enzymes 
along with cellobiohydrolase I (CbhI) gene, which comprise the major part of the total extracellular 
protein produced by the fungus (Pakula et. al., 2005).  
For almost a century, Trichoderma spp., have been widely applied as biocontrol fungi due to their 
beneficial effects on plants and soil. Thus, they have been extensively studied using a variety of research 
approaches, including genomics, transcriptomics, proteomics, and metabolomics, etc..  A successful case 
of translational research, in which omics-generated novel understanding is directly translated into new or 
improved crop treatments and management methods (Lorito et. al., 2010).  
Moreover, with the systematic improvement of production, it was reported T. reesei could produce over 
40 g/liter of extracellular protein. Also, due to its excellent secretion capacity and cheap easy cultivation, 
T. reesei is also a potential host for the large-scale production of heterologous proteins (Chen et. al., 2010; 
Nakari-Setala & Penttila, 1995). Particularly, filamentous fungi, as cellulolytic organisms, are of great 
interest to industrialists because they have the capacity to produce exceptionally large amounts of 
extracellular enzymes (Ferreira et. al., 2011).  For example, T. reesei is primarily used for the production 
of its native cellulolytic and hemicellulolytic enzymes. However, during the last two decades, T. reesei 
has been used as a host to express numerous recombinant proteins. Early examples of this work include 
two mammalian proteins: bovine chymosin and antibody Fab fragments. The Fab production was greatly 
improved when the heavy chain gene was fused with the native cellobiohydrolase CbhI serving as a 
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secretion carrier to the Fab. Some studies suggest that there are spatial restrictions in secretion of foreign 
proteins whereas native proteins with native CbhI can greatly enhance its secretion out of the cells 
(Saloheimo & Pakula, 2012).  
Furthermore, advancement in biotechnology especially in the area of genetics, protein engineering, 
developments in bioinformatics, and the availability of sequence data have opened a new era of enzyme 
applications in many industrial processes (Dahiya et. al., 2006). In addition, genetic transformation is an 
essential part of modern fungal research requiring the production of protoplasts (i.e. cells are stripped of 
their walls by enzymatic digestion) (Turgeon et. al., 2010). However, the recovery of protoplasts might be 
problematic, especially in slow growing species and the results may vary considerably between different 
enzyme batches resulting in inconsistent transformation efficiencies (Minz and Sharon, 2010). Strategies, 
such as the use of specific lytic enzymes, to remove the cell wall along with optimum timing can improve 
protoplast production; the choice of enzyme for digesting the cell walls being a key factor. Also, 
protoplasts are osmotically stabilized with sodium chloride, magnesium sulphate, mannitol, and sorbitol or 
sucrose. On the other hand, mutant strains transformed less efficiently for reasons that have not been 
properly investigated or understood (Ferreira et. al., 2011).  
In the last century, with the development of biotechnologies, the importance has extended beyond 
agriculture, into enzyme production, food industry, paper and pulp treatment, bioremediation, etc.; T. 
reesei continues being studied extensively. Almost 80 years ago, it was discovered that Trichoderma spp. 
have the ability to attack and control plant pathogenic fungi. Thus, a complex system for fungal prey 
detection was developed through the study of antagonistic mechanisms in Trichoderma, which 
demonstrated the involvement of many hydrolytic enzymes, also capable of acting synergistically with 
highly fungiotoxic antibiotics. More so, Trichoderma enzyme-encoding genes have been used in studies to 
improve plant resistance to pathogens and salt stress, yet none of the resulting transgenic cultivars have 
been commercialized (Lorito et. al., 2010). Structural and functional genomic investigations are making 
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an important impact on the current understanding and application of microbial agents used for plant 
disease control. 
In this study, we present one of the latest discoveries on the Trichoderma expressome which may have 
demands in pharmaceutical and industrial applications; the production of economically competitive 
recombinant T4L from genetically engineered T. ressei. Specifically, I aimed to improve T. reesei strain 
genetically, for the production of a novel strain hosting a synthetic t4l. Successful evaluation of 
recombinant T4L production through this genetically engineered system is challengeable
4.2. Materials and Methods  
4.2.1. Strains, Media, and Cultivation Conditions 
In this study, two T. reesei strains were used; QM6a and its mutant QM9414, for the possibility of 
expressing a synthetic t4l after transformation. Fungal strains, were grown on the surface of two kinds of 
agar plates; Potatoes Dextrose Agar (PDA) (15.0 g/L potato dextrose broth, 20.0 g/L D-glucose, and 18.0 
g/L agar) and/or Yeast extract Glucose (YG) agar (5.0 g/L yeast extract, 20.0 g/L D-glucose, and 14.0 g/L 
agar) (Benko et. al., 2007); with no antibiotic supplementation. The former were used for spore-forming 
growth, while the latter for mycelium-forming growth. Plates were incubated at 30˚C for 24 h and were 
then kept upside-down for approximately 10 days at same temperature. Of note, plasmids bearing-
synthetic-t4l, which were QS, QL, and T4L-pET20b(+), contain hygromycin B phosphotransferase (hph) 
resistance gene; therefore, 25 µl/ml hygromycin B (BioShop, Canada) was used as the selection marker to 
maintain selection of positive clones.  
4.2.2. Antifungal Plate Assay 
The commercial lysozyme was examined towards hyphal growth of T. reesei on agar plates, as 
described previously (Mizuno et. al., 2008). T. reesei QM6a and QM9414 were used as test fungi. 
Antifungal plate assay is basic test to determine whether lysozyme has hydrolysis activity on agar plate 
growth of T. reesei. Therefore, this assay was used to determine if any difficulties will occur during 
expression of a synthetic t4l in these organisms. Briefly, seven sterile paper discs were placed on fresh 
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PDA plates away from the center of the plate by 15 mm each. Next, grown spores were collected from 
fresh agar plates by adding 3 – 5 ml of 0.9% NaCl on the top of agar with use of a glass spreader to collect 
most of the grown spores. Then, an autoclaved funnel containing 12 lens papers (Fisher Scientific, 
Canada) were used to separate spores in the filtrate, from mycelium. After, the spore concentration was 
adjusted to ~ 1 X 106 spores/ml, and 200 µl of spores were added to the paper disc in the center of PDA 
agar plate. Subsequently, the plates were incubated for 24 h at 30°C; different volumes of commercial 
lysozyme (Sigma-Aldrich, Canada) with final concentration 20 µg/ml was applied to the paper discs; as 
follows: 1µl, 5 µl, 10 µl, 15 µl, 20 µl, and 30 µl, while the negative control included 10 µl of autoclaved 
ddH2O. Finally, agar plates were re-incubated at 30°C for a final 24 h; then placed upside down. 
Visualization of hydrolysis of T. reesei growth was followed until growth of spores reached the edge of 
the plate, and then pictures were taken. 
4.2.3. Protoplasts Preparation and Genetic Transformation 
T. reesei QM6a protoplasts were prepared using a new method developed through the modification of 
Szewczyk et. al., (2006) protocol (Szewczyk et. al., 2006). To begin, spores were collected from T. reesei 
QM6a, as previously described using 3 – 5 ml of 0.9 % NaCl  and a glass spreader; then, 12 lens papers 
were used for separation the spores from the mycelium. Following, one drop of the filtrate was used to 
count spores with a Petroff-Hausser cell counter (American Optical, USA) under a microscope and spore 
concentration was adjusted to ~ 1 X 108 spores/ml. Thereafter, 1 ml of the spores was added to 100 ml YG 
broth with 0.6 M KCl, including 40 µl of trace elements. Glass flasks were then incubated at 30˚C, 
shaking at 200rpm for ~ 16 h; the grown hyphae was harvested by 12 filter papers, then myceliun 
collected and inoculated in 40 ml YG broth with 16 µl of trace element, plus, 40 ml of 2X protoplast 
solution (5.12g Novozyme mixed with 40 ml KCl-citric acid, filtered through 6 filter papers, using a 
syringe). This mixture was incubated at 30˚C, shaking at 75 rpm, for 1.5 - 2 h. After the incubation period, 
mycelium was removed using 8 filter papers with the funnel standing against the flask wall to obtain good 
protoplast yield. Next, the mixture containing protoplasts was centrifuged for 10 min at 1,800 g and 
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supernatant discard, then, 15 ml of 0.6 M KCl was added, followed by centrifugation for 10 min at 1,800 g 
and the supernatant discarded once again. The pellet was then resuspended in 2 ml of 0.6 M KCl and 
transferred to two sterile 1.5 ml microcentrifuge tubes in 1 ml aliquots. Again, pellet the protoplasts were 
centrifuged at 2,400 g for 3 min, then supernatant discarded and the pellet resuspend in 1 ml of 0.6 M 
KCl; this step was repeated twice. Thereafter, the pellet was resuspended in 1 ml (0.5 ml in each tubes) 
0.6 M KCl, 50 mM CaCl2, and centrifuged at 2,400 g for 3 min.  
For transformation, 10 - 15 µl of QS, QL, and T4L-pET20b(+) plasmids were independently mixed 
with 100 µl of protoplasts by vortexing 6 - 8 times for 1 s at maximum speed. Subsequently, 50 µl of PEG 
solution was added, then vortexed 4 - 5 times for 1 s at maximum speed; all tubes were chilled on ice for 
15 min before 0.5 - 1 ml of PEG solution was also added. Next, tubes were incubated at room temperature 
for 25 min, and 100 ml of pre-warmed YG-sucrose agar, containing 40 µl of trace element and 25 µg/ml 
of hygromycin, was added and poured into small petri dishes. Finally, all plates were incubated at 30˚C, 
and monitored for 12 – 24 h, and then transformants were screened on PDA plates containing 25 µg/mL 
hygromycin B as the selection marker.  
4.2.4. Confirmation of Positive Clones 
4.2.4.1. Genomic DNA Isolation and st4l Amplification 
Firstly, T. reesei QM6a transformants were grown after single spore-separation. Then, the genomic 
DNA was extracted using the UltraClean Microbial DNA Isolation kit (MO BIO Laboratories Inc., 
Carlsbad, CA) following the provided protocol by supplier. Following, the genomic DNA extracts were 
used as a template in PCR to amplify the approximate 510 bp sequence of synthetic t4l using the 
following primers designed in conserved region: T4L-Primer 5 Forward (FW 5`-TCC CAT ATG AAC 
ATC TTC GAG AAG TTG AGA-3`) and T4L-Primer 6 Reverse (REV 5`-ATA CTC GAG CAA GTT 
CTT GTA AGC GTC CCA-3`). The PCR reaction contained 10 ng of genomic DNA individually from 
each extracted genomic DNA, 10 pmol of forward and reserve primers, 10x Taq buffer with KCL 25 
mmol l-1 MgCl2, 0.2 mmol deoxynuclotide triphosphate, and 5 U Taq DNA polymerase per 50 µl reaction. 
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The PCR program was as follows: primary denaturation 5 minutes at 95˚C, followed by 30 amplification 
cycles consisting of denaturing at 94˚C for 1 minute, annealing for 1 minute at 60˚C, and extension at 
72˚C for 1 minute, upon completion of 30 amplification cycles at final extension step was done at 72˚C 
for 10 minutes and finally the reaction was held at 4°C. Ultimately, the PCR products were then viewed 
on a 1% agarose gel to confirm size and photograph under UV illumination.  
4.2.4.2. Transformants Identification and Sequencing  
Previously extracted genomic DNA of transformants was sequenced using standard run modules on the 
ABI 3730xl automatic sequencer (Eurofins MWG Operon, Canada). Sequencing results were individually 
inputted online into the nucleotide BLAST tool through the NCBI database (http://blast.ncbi.nlm.nih.gov/) 
to identify the homology of synthetic t4l sequence to the general nucleotide database. The percentage of 
inquiry coverage was recorded.   
4.2.5. Detection of Recombinant T4 Lysozyme   
Three transformants were selected in T4L production experiments, along with two different strains of 
T. reesei as negative controls, QM6a and its mutant QM9414. Firstly, all strains were grown and 
maintained on PDA agar plates and after 10 days incubation at 30°C, spores were suspended in ~ 5 ml 
0.9% NaCl. Spores were then separated from the mycelium as previously described and counted using a 
Petroff-Hausser cell counter (American Optical, USA). Next, isolated spores were added to a final 
concentration of ~1 x 106 spores/ml to 250 ml flasks containing 50 ml Mandel and Andreotti (MA) 
medium, as described by Mandel and Andreotti (1978) (Mandel & Andreotti, 1978) with 1% (w/v) 
glycerol as a sole carbon source (the media was autoclaved at 121°C for 15 min); cultures were then 
incubated on a rotary shaker (200 rpm) at 30˚C. Pre-grown mycelia were washed thrice with MA medium 
containing no carbon source to remove any residual glycerol. Then, mycelia were transferred into 250 ml 
flasks containing 50 ml MA medium with 1% glycerol (w/v). Subsequently, to determine recombinant 
T4L production, a time course trial was conducted similar to that of Cianchetta et. al., (2010) (Cianchetta 
et. al., 2010). Specifically, the flasks were incubated at 30°C, shaking at 200 rpm for a total of 60 hours. 
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Finally, samples of 500 µl were taken from each flask every 24 h in a biosafety cabinet to maintain 
sterility. These 500 µl samples were centrifuged at 13000 rpm for 5 min, and the supernatant was used as 
the source of enzyme (Benko et. al., 2007). 
SDS-PAGE has been used to separate proteins according to their electrophoretic mobility. Definitely, 
adjusting the gel concentration based on the molecular weight of protein, in our case, 12% resolving gel 
was used for denaturing SDS-PAGE, while for stacking gel 5%. Also, using tetramethylethylenediamine 
(TEMED) with both gels was essential. TEMED was used with ammonium persulfate (APS) to catalyze 
the polymerization of acrylamide when making polyacrylamide gels. Therefore, after it was added to the 
solution, gel casted right away. All collected samples set were prepared as follow: 24 µl of sample mixed 
with 2 µl of reducing buffer and 10 µl of dye. After mixing the samples, they were boiled for 5 min at 
100˚C, before loading 10 µl in the gel. Next, the samples were loaded in the gel followed by attaching the 
power supply, and 80 V was used first for 10 – 20 min, after that, the voltage increased up to 110 V, for 
approximately two hours.  
After running an SDS-PAGE gel, gel was washed with dH2O several times gently. Definitely, there are 
several kinds of staining that have been used for staining the SDS-PAGE gel such as, PageBlue, 
Coomassie, and Silver staining. Here, coommassie staining was used by putting the gel in container for 
staining by coomassie blue staining solution and kept in staining solution for 30 min with gentle shaking 
(60 rpm). Then, stained gel was washed with H2O and putted in a clean tray and coomassie blue 
destaining solution was added to remove the stain from the gel for overnight. Next day, the gel was 
washed with H2O and photographed. The expect band for T4L should has a molecular weight of 
approximately18 kilodalton (kDa). 
4.3. Results and Discussions  
4.3.1. Strain optimization and Halo Assay 
The concentration of hygromycin B was critical; low concentration resulted in high background 
causing an inability to distinguish transformants from the agar plate, whereas at high concentrations there 
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are no colonies. Therefore, 25 µg/ml hygromycin B was the optimal concentration which would allow the 
development of low background after 24 – 48 h, and has been used as a selection marker for 
transformation of T. reesei. 
Additionally, halo assay results showed that commercial lysozyme has the ability to inhibit the hyphal-
growth on agar plate assay (Figure 1). In other words, lysozyme was considered as an antifungal agent, 
based on the results. The inhibition of hyphal extension has been explained by the presence of chitin as an 
important constituent of fungal cell wall. Chitin, a β-(1,4)-linked polymer of two NAG, is widely 
distributed in nature, particularly as a structural polysaccharide in fungal cell walls (Dahiya et. al., 2006; 
Okazaki et. al., 2004). Several reports are available regarding the presence of chitin in fungal cell walls. In 
filamentous fungi, it comprises 16% of the dry weight of the organism. In addition, chitin has the same 
β(1-4) glucosidic bonds as the bacterial PG, except that the bond links two NAG residues instead of an 
NAG and NAM (Dahiya et. al., 2006). On the other hand, chitinases, which hydrolyze chitin, occur in a 
wide range of organisms including viruses, bacteria, fungi, insects, higher plants, and animals (Okazaki et. 
al., 2004, Watanabe et. al., 1999). The roles of chitinases in these organisms are diverse. For example, 
chitinases have been implicated in plant resistance against fungal pathogens because of their inducible 
nature and antifungal activities in vitro. Additionally, chitinase in fungi is thought to have autolytic, 
nutritional, and morphogenetic roles. Moreover, chitinases can also be used in agriculture to control plant 
pathogens, as shown in immense potential for increasing the production of several useful products 
economically (Dahiya et. al., 2006). Therefore, lysozyme could be considered as a good chitinase based 
on our results; because, lysozyme had the ability to lyse chitin of fungal cell wall as was shown in the halo 
assays (Figure 2). Also, lysozyme possesses chitinase activity, however there is no obvious amino acid 
sequence similarity found between these two types of enzymes. 
4.3.2. Production of Protoplast and Genetic Transformation 
The procedure for producing transformable protoplasts from grown hyphae was described here in 
detail. This procedure used Novozyme, as a selected enzyme, and could be easily scaled to produce larger 
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quantities of protoplasts. Figure 3 shows transformable protoplasts produced from T. reesei QM6a. 
Similarly, a transformation procedure was described here and transformations were successful with initial 
observations of growth on agar plates. Consequently, wild-type T. reesei QM6a did not grow well on agar 
plates when 25 µg/ml hygromycin was used; therefore, the observational growth of transformants was a 
strong signal for positive colonies. Most of the positive colonies appeared after 2 days and were 
transferred to fresh PDA only when a clear colony was produced, which usually takes 3 days. 
Furthermore, additional colonies appeared during several days, these were also stored. Three mitotic 
stable hygromycin-resistant transformants were selected by single spore isolation to insure pure cultures. 
The three transformants (ST4L1, ST4L2, and ST4L3) were cultured for more than 8 generations. 
4.3.3. Confirmation of Positive Clones 
4.3.3.1. Characterization of T4 Lysozyme Transformants 
The integration of synthetic t4l gene into the genome of T. reesei QM6a was confirmed by PCR and 
sequencing using primers designed to target full size of synthetic t4l, with an expected size of 510 bp 
(Figure 4). However, the migration of PCR products’ bands on agarose gel determined that both 
transformants and wild-type had similar bands sizes on the gel. In another words, there were bands with 
same molecular weight and size of synthetic t4l, from both transformants and QM6a as well QM9414; 
when the above mentioned primers were used. Therefore, new primers were designed; before that, both 
primers were aligned to the genomic DNA sequence of T. reesei QM6a, which was available onto NCBI 
under accession number AAIL00000000, to identify region of the T. reesei genome had similarity with the 
existing primers. This was a defined gene: bifunctional dethiobiotin synthetase/adenosylmethionine-8-
amino-7-oxononanoate aminotransferase (bioDA), which is available in NCBI under accession number 
BK007868, and its size is 2736 b.p.. Then, the nucleotide sequence of bioDA gene was recorded and 
aligned to synthetic t4l using MultAlin software (multiple sequence alignment by Florence Corpet) 
(Corpet, 1988). After analysis, I explored the possibility of designing new primers to target a small of 
portion of synthetic t4l only; there were however, high conserved residues between both nucleotide 
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sequences as presented in Figure 5. Thus, a newly designed set of primers would be unspecific to 
synthetic t4l.  
4.3.3.2. Positive clone Identification and Relevancy  
Sequencing results were obtained for all positive clones, and sequencing analysis was performed twice 
for each sample (i.e. extracted genomic DNA of transformant); one sequencing result with forward primer 
and the other result with reverse primer. Each resulting sequence was then inputted to the nucleotide 
BLAST feature of the NCBI database to obtain possible identities based on homology to database, 
synthetic t4l, genomic DNA of T. reesei QM6a, and bioDA gene. The nucleotide BLAST results are 
shown in Table 1. From BLAST search results, confirmation of ST4L1 and ST4L3 was determined based 
on 97-98% homology compared to other synthetic T4L genes in the database, with the exception of low 
(69% homology) for ST4L2 to the same gene mentioned above. However, the similarity of sequencing 
results to the nucleotide sequence of synthetic t4l yielded 98-100% homology with ST4L1, 34-70% with 
ST4L2, and 97% with ST4L3. Additionally, all positive clones displayed no significant similarity to both 
bioDA and genomic DNA of T. reesei, while ST4L2 was found to have low percentage of similarity (3% 
homology) to bioDA. In conclusion, these results showed the insertion of synthetic t4l into the genomic 
DNA of T. reesei QM6a was successful with the three plasmids bearing synthetic-t4l.  
4.3.4. Detection of Recombinant T4 Lysozyme Production  
After confirmation of the successful integration of synthetic t4l gene into the genome of T. reesei, via 
both PCR targets and sequencing, I explored how synthetic t4l could be expressed in the media. 
Supernatant samples were collected from transformants and control every 12 h of incubation for a total 72 
h and ran on SDS-PAGE gel. However, samples collected with 12 h, 24 h, 36 h, and 72 h incubation did 
not display significant bands; thus, indicating a lack in presence of recombinant T4L (gel image not 
provided). Nonetheless, the set of samples collected after 48 h incubation, had very clear bands for two 
transformants, ST4L2 and ST4L3, which was not shown in the negative control (native T. reesei QM6a). 
In addition, there was clear induced band present in ST4L3 sample collected after 60 h incubation. These 
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bands had molecular weight of approximately 15 kDa, which is not the exact molecular weight of the 
native T4L (approximately 18 kDa) (Figure 6). The slight molecular weight reduction of the recombinant 
protein could be due to RNA processing, including pre-mRNA and mRNA, which are followed by mRNA 
translation to protein in the fungus; as it is eukaryotic organism. In other words, a gene is first transcribed 
into a pre-mRNA, which is a copy of the genomic DNA, containing intronic regions to be removed during 
pre-mRNA processing (called RNA splicing) as well as exonic sequences that are retained within the 
mature mRNA. In conclusion, the results of SDS-PAGE were an excellent indication of successful 
expression of the synthetic t4l in T. reesei system. The SDS-PAGE indicated that it is very likely the T4L 
protein was produced, but a western blot verification is necessary.  
Conclusions 
The development of genetic transformation systems has been an essential factor in the advancement of 
recombinant DNA techniques. However, the development of genetic transformation systems for species in 
which none exists can present significant challenges; thus, it is pertinent to collect methods which have 
been successfully applied to other species and determine through troubleshooting how best to apply them 
to the target organism. Transformation is an essential part of modern fungal research. Moreover, the 
number of filamentous fungi which have been genetically transformed has increased, thereby opening the 
door to more detailed molecular projects. This study represents one of the cutting-edge fungal 
biotechnology works illustrating the development of protoplast-based transformation of T. reesei, for the 
purpose of expression and production of antimicrobial enzyme; T4L enzyme. The use of genetically 
improved T. reesei strain is allows limited microbiological contamination during an industrial process. 
Especially, T. reesei is of great interest to industrialists because they have the capacity to produce 
extracellular enzymes in very large amounts.  
According to this study, the method of protoplast-based transformation presented here was efficient, 
allowing for the production of heterologous proteins such as here recombinant T4L, as an example. 
Moreover, I was able to extract a heterologous protein from the media easily using CbhI promoter. 
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According to this study, fungal protoplasts have been used as an effective experimental tool in strain 
improvement for biotechnological applications. We have successfully modified the genomic DNA of three 
transformants: ST4L1, ST4L2, and ST4L3, with potential for industrial use in limiting the contamination 
through the production of this antimicrobial agent. These transformants may lay the foundation for the 
current exploitation of this enzyme by further investigation. Also, these transformants may have great 
potential for developing fungal biotechnology in the near future to enhance the sterilization and help 
overcome costly hurdles being faced in the industrial production of antimicrobial agents. 
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Table: 
Table 1: Sequencing results along with BLAST search results 
Table 12:  
Transformant Sequencing Results 
Primer 
Used Alignment to 
Similarity 
(%) Description 
ST4L1 
ST4L1-6 FWD 
Database 98% Synthetic T4 lysozyme gene, complete cds 
Synthetic t4l 100%  
T. reesei QM6a gDNA  0  
bioDA gene 0  
ST4L1-5 REV 
Database 71% Synthetic T4 lysozyme gene, complete cds 
Synthetic t4l 98%  
T. reesei QM6a gDNA  0  
bioDA gene 0  
ST4L2 
ST4L2-6 FWD 
Database 0  
Synthetic t4l 34%  
T. reesei QM6a gDNA  0  
bioDA gene 0  
ST4L1-5 REV 
Database 69% Synthetic T4 lysozyme gene, complete cds 
Synthetic t4l 70%  
T. reesei QM6a gDNA  3% bioDA gene 
bioDA gene 3% bioDA gene 
ST4L3 
ST4L3-6 FWD 
Database 0  
Synthetic t4l 0  
T. reesei QM6a gDNA  0  
bioDA gene 0  
ST4L1-5 REV 
Database 97% Synthetic T4 lysozyme gene, complete cds 
Synthetic t4l 97%  
T. reesei QM6a gDNA  0  
bioDA gene 0  
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Chapter V: General Discussion and Future Directions 
Enzymes that are able to hydrolyze cell membrane polymers generally play important roles for 
protecting plants and animals against infection by insects and pathogens. All of the work presented here in 
this thesis approaches the challenge of expressing a codon-modified gene encoding T4L protein in 
different microorganisms with a main focus on the expression of that gene. The research presented in this 
thesis led to the discovery of the possibility of T4L-producing bacteria as well as fungi with potential in 
future studies for the characterization and exploitation of that enzyme for protecting plants and animals 
against infection by insects and pathogens. Additionally, this work lends knowledge to the future study 
and use of T. reesei in simultaneous production of antimicrobial agents. However, until now there has 
been no global industrialization of T4L. Currently, there are several challenges in producing this enzyme.  
Firstly, my work focused on studying the synthetic t4l bioinformatically. With that work, the synthetic 
t4l has been compared to its native nucleotide sequence, and then the 3D protein structures of both 
proteins were analysed. The findings allowed us to determine the variation between these T4Ls in 
computational biology to demonstrate the results of codon bias modification on the nucleotide sequence 
onto the amino acid sequence. The two altered amino acids found in this study have shown the average 
distance between atoms when the backbone coordinate was calculated by RSMD. However, these results 
gave us a quantitative comparison between the structure of a partially folded protein and the structure of 
the native state. This shows us how well a submitted structure matches the native state, which raises 
predictions on whether the produced enzyme will be in an active or inactive state after its expression in a 
microorganism. Further, if it is in an inactivate state, the question will be whether this is related to the 
codon-based modifications or due other biological approach matter. Whatever the end result, future work 
is required for understanding the T4L from a bioinformatics approach. This includes studying the genetic 
variation of other mutants in the database and/or synthetic T4L genes that have been used with other 
studies. Because the genetic variation of this enzyme has increased the demand to uncover it via a 
bioinformatics approach, there will be an advantage of effective mutations and/or modifications occurring 
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in specific genetic regions. Application of such an approach will be useful to unclassified mutations as 
well as provide strong support for those interested in working on this protein at advanced levels or in the 
literature. Moreover, predicting the effects of amino acid substitutions on protein function by using 
computational biology will be very useful for further research in terms of time and cost. Some genetic 
variations are neutral, but single base changes in and around a gene can affect its expression or the 
function of its protein products. Nonsynonymous single nucleotide polymorphisms (nsSNPs) are coding 
variants that introduce amino acid changes in their corresponding proteins. However, nsSNPs can affect 
protein function. Therefore, it is important to distinguish those nsSNPs that affect protein function from 
those that are neutral, super-expressed, and more stable functionally. In addition, amino acid substitution 
(AAS) prediction methods could be applied to this benchmark, which use sequences and/or structure to 
predict the effect of an AAS on protein function. 
In my second study, I used a well-known molecular biology technique in the incorporation and 
expression of exogenous genetic material—synthetic t4l—in a bacterial cell. There were several reasons 
for working on a bacterial strain at the beginning. First, bacteria can be easily cultured and manipulated 
with the transformation. Second, bacteria have long been used in the field of molecular biology. These 
attributes lend to the potential exploitation of producing recombinant enzymes by identifying a bacterial 
strain that is commonly used in laboratory settings for genetic alteration and that could also produce 
certain enzymes with antimicrobial properties. After confirming the resistance of the E. coli 
BL21(DE3)pLysS strain towards the commercial lysozyme, our transformants successfully carried out our 
plasmids and manipulated them. In addition, our transformants displayed a successful expression of our 
synthetic t4l. Thus, our transformants BL21(DE3)pLysS with plasmids bearing t4l successfully produced 
T4L. However, the T4L enzyme produced needs to be measured and its activity characterized. This can be 
accomplished with two methods: plate bioassay and turbidity assay. These two assays will complement 
each other to determine and measure the recombinant T4L production. Plate bioassay is based on plate 
growth inhibition by visualizing the clear zone of the agar plate. Growth inhibition will be indicated by a 
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clear zone on the agar plate, whose diameter will be proportional to the catalytic activities of the enzyme. 
M. luteus is a good candidate to be used as a test strain, and in this case commercial lysozyme could be 
used as a positive control. Thus, plate bioassay is simple and a good choice for determining T4L activity. 
On the other hand, measuring the production of recombinant T4L could be performed by turbidity assay. 
A spectrophotometer could be used to find the measurement of turbidity in liquid, with M. luteus again 
used as a test strain. The activity of recombinant T4L will be determined by measuring the decrease in 
optical density of a tested strain. Also, the thermostability and pH effects of the enzyme could be tested in 
the same manner. Not surprisingly, researches have produced a recombinant T4L; however, it appears to 
be inactive, probably due to the absence of correctly formed disulphide bonds. For instance, incorrect 
folding of T4L resulting in an enzymatically inactive protein has been reported in E. coli under conditions 
of overproduction (van de Guchte et al., 1992). 
In addition, over the past few decades a number of reports have highlighted the growing importance of 
electrochemical biosensing devices in both clinical and environmental analyses. This may not seem as 
surprising when one considers that electrochemical transduction processes have inherent advantages, such 
as low cost, high sensitivity, independence from solution turbidity, simple miniaturization that is well-
suited to microfabrication, low power requirements, and relatively straightforward associated 
instrumentation. These characteristics make electrochemical-biosensing methods highly attractive in 
myriad applications, including the detection of cancer, infectious diseases, and biological compounds (for 
example T4L), to name a few. The aims of the biosensor work will include the development of a detection 
method for T4L using Surface Plasmon Resonance (SPR) technology, for example, which will produce a 
detection system with a greater throughput and a greater limit of detection. An anti-lysozyme aptamer will 
be used as a receptor for T4L in a buffered sample. Part of the T4L biosensor method will include the 
regeneration of the sensor chip for further lysozyme measurements in general. Once this system has been 
established and optimized, then samples will be tested. A comparison of the T4L content will be measured 
by ELISA, and the biosensor method will be carried out as a confirmatory test. 
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The remaining focus of my studies was to utilize molecular biology techniques to further improve a 
known extracellular enzyme-producing fungal system. I chose the well-known filamentous T. reesei, 
which is used for cellulase and other industrial applications related to biorefining. There were many 
advantages for choosing this strain over E. coli. T. reesei is eukaryotic, and thus a foreign gene can be 
integrated into the filamentous fungus genome and stable transformants obtained. Also, it is well known 
that this fungus secretes proteins extracellularly along with inducer regulation by a strong promoter, and 
post-translational modification and well-established fermentation technology has been applied to this 
strain in other studies. Additionally, T. reesi is non-toxic to humans and animals, resulting in a stain that 
has no side effects and is cost effective during the industrial production of the antimicrobial agent T4L. In 
addition, genetic transformation is an essential part of modern fungal research. Primarily, protoplasts’ 
production and recovery might be problematic, especially in slow growing species. It is also known that 
results vary considerably between different enzyme batches, resulting in inconsistent transformation 
efficiencies (Minz and Sharon, 2010).  
Thus, my next project focused on the development of a genetically engineered strain of T. reesei 
QM6a, which is capable of producing an antimicrobial agent. The addition of exogenous T4L gene 
originated from bacteriophage T4 proved to be a substantial challenge in producing recombinant T4L with 
such a system. Thus, I chose to express our synthetic t4l in T. reesei QM6a. Due to the difficulty in 
genetic modification of T. reesei and due to time constraints, I chose a number of methods that generated 
genetically modified strains by using the fungal system in general. Then, I tried to match the most similar 
steps in those protocols and considered the major different steps. From a historical perspective, the first 
eukaryotic organism to be transformed was Saccharomyces cerevisiae in 1978 (Hinnen et al., 1978), and 
the first filamentous fungus transformed was the saprobe Neurospora crassa (Case et al., 1979). These 
achievements were followed by the transformation of the saprobe Aspergillus nidulans in 1984 (Yelton et 
al., 1984). The efficiency of transformation, i.e., the fraction of cells that take up DNA, is low (Turgeon 
et. al., 2010); therefore, a strategy was used here to identify those cells that have been transformed, which 
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was the introduction of a selectable marker that transforms the original strain from drug sensitive to drug 
resistant. That strategy was much easier to work with during the transformation process. In our plasmids, 
the hygromycin phosphotransferase (hph) gene was used, which confers resistance to hygromycin B as a 
selectable marker. A number of choices for drugs are available and sensitivity of protoplasts to the drug 
should be experimentally determined on the solid medium for the fungal strain used for transformation. In 
the study, a range of hygromycin B concentrations were tested on the growth of T. reesei QM6a on PDA 
agar plates, and 25 µg/ml was the optimal concentration for transformants. During this study, I was able to 
design a modified protoplast-based modification to be used in future studies for T. reesei genetic 
modification. I also expressed synthetic t4l from QS, QL, T4L-pET20b(+) plasmids and saw a significant 
production with SDS-PAGE.  
Therefore, in my last study, I investigate the development of the stable transformant of T. reesei QM6a 
carrying our synthetic t4l. The developed system here lends knowledge for future improvements. Our 
method of producing transformable protoplast could be applied by using other genes of interest with the 
QM6a strain, while a synthetic t4l into the genome of T. reesei QM6a strain was successfully engineered 
and the enzyme produced extracellularly. I propose that development of a novel strain that produces both 
chitinase and lysozyme, as both are key enzymes in the plant defense system against fungal infection, will 
have huge value in the industry. However, during this study I note some important factors that could affect 
application of the discussed protocol in this thesis, which lends knowledge towards future studies. Firstly, 
the lytic enzyme used can alter the overall transformation rate. Novozyme is widely used; however, it does 
not always work well (Turgeon et al., 2010). In some cases, it may be difficult to digest cell walls if 
grown too long, so fresh sample is always recommended. Also, adjusting the time from adding lytic 
enzyme to generating protoplasts is critical. Losing produced protoplasts in this step happens with 
different laboratory conditions. Secondly, a lower concentration of osmotic stabilizer is utilized in the 
medium on which the transformants are plated. Subsequent chilling of the protoplasts in the presence of 
divalent cations such as Ca2+ (in CaCl2) renders protoplasts permeable to DNA and thus “competent” to 
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take up DNA (Turgeon et al., 2010). Thirdly, strains carrying mutations could transform less efficiently 
for reasons that have not been investigated in detail and are not yet understood. Of note, quality of 
protoplasts deteriorates upon storage. We do not recommend using frozen protoplasts for important 
experiments, since the entire transformation procedure is labor intensive. 
Although it is beyond the scope of this protocol to discuss the handling of transformation and 
assessment of transformants in detail, it is absolutely necessary to verify that transformants have the 
correct insertion. Gene replacements could be analyzed by quantitative Real-Time PCR (qRT-PCR). 
Spores are streaked on selective media to allow growth of single colonies. DNA is extracted from these 
colonies and tested. This will show whether an insertion of the right size is present in the right place in the 
genome; it will also verify that a single correct insertion has occurred and that no insertions have occurred 
elsewhere in the genome. The copy number of the synthetic t4l integrated into the T. reesei genome of the 
transformants will be known by this analysis. If transformants obtain more copy of the synthetic t4l, their 
enzyme productions will be compared to those with fewer copy numbers. 
Additionally, if there is time, my continuing work will be related to the effects of growth rate on 
protein synthesis and secretion in the filamentous fungus T. reesei. Very little information is available on 
the cellular responses to protein production. T. reesei has the potential to produce extracellular proteins in 
very large quantities, which sets a demand for the cells to adjust the capacity of protein synthesis and 
transport to the level required, and may also provoke stress responses within the cells. To obtain 
information on protein production and factors affecting the processes at different growth rates of the 
organism, carbon-limited chemostat cultures of the strain QM6a, both wild-type and our transformants, 
must be analysed in detail under different physiological conditions and under the influence of different 
factors affecting protein production by the fungus. Specifically, the capacity of the cells to synthesize and 
secrete proteins could be studied using metabolic labeling of the proteins after setting up a methodology 
for analysis of protein synthesis and secretion in a defined culture condition. In addition, the expressions 
of the major cellulose gene cbhI, as well as genes involved in protein folding and transport, have to be 
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analysed under these conditions. This study could offer new insight into the protein production 
characteristics of the industrially important host organism T. reesei (Pakula et al., 2005). Also, genetic 
modification in fungal organisms continues to advance, rendering greater opportunities for the 
development of economically feasible greener technologies to produce enzymes for biorefining 
applications.    
In conclusion, the synthetic t4l has been successfully studied and expressed in both biological systems; 
E. coli and T. reesei, and T4L-producing transformants have potential for further study. This thesis project 
still has huge potential. If more time was allowed, several additional experiments would have been 
included to both extend work executed in all chapters and also to explore other avenues in the hope of 
producing better tests and results. In brief, all of the transformants that are known to be T4L-producing 
transformants must have their activities measured towards the known bacterial sensitivity and/or 
resistance to lysis activity of the enzyme to determine how similar our modified enzyme is to the native 
T4L. This will allow us to determine the practicality of these transformants in an industrial setting while 
addressing industrial, environmental, technical, and economic challenges.  
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